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ABSTRACT 
 
“Mother Nature” provided 4 homologues (α, β, γ, δ) of tocopherol, all of which are 
components of the naturally produced Vitamin E. They have the same ring structures and 
sidechains, but they differ from each other in the extent of methylation in their aromatic 
ring. 
 
 
 
 
 
 
 
 
 
 
The various homologues have different activities, with the most methylated, α-
tocopherol, being the most active yet being the least stable due to the congestion caused 
by the six substituents attached to the benzene ring. 
 
The free radical scavenging mechanism which leads to a quinoidal structure via a radical 
oxidative ring opening is exothermic.  However, the ionic oxidative ring opening is 
endothermic.  Consequently, the ionic reductive ring closing is exothermic. 
 
This leads to the suggestion that Vitamin E may be recovered unchanged, thus it 
effectively it becomes a catalyst for the following reaction. 
 
2HOO· + H3O(+) + NADH          2HOOH + H2O + NAD(+)  ∆E=-120.18 Kcal·mol-1 
 
Vitamin E is “recycled” biologically and as a single α-tocopherol molecule may convert 
numerous HOO· radicals to H2O2. These peroxide molecules will accumulate if not 
removed enzymatically at the formation rate through the participation of Catalase(Fe) or 
Glutathione Peroxidase, GPx(Se).  This accumulation of peroxide, which may be referred 
to as a “peroxide traffic jam”, may be the reason for the pro-oxidant effect of Vitamin E. 
This may be regarded as the molecular explanation of the poetic expression that Vitamin 
E is considered as a “Janus” molecule with anti-oxidant and pro-oxidant activity. 
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DISCLAIMER 
 
 Vitamin E was discovered in 1922 taking a considerable length of time to be 
recognized for its anti-oxidant activity. The medical importance of tocopherols and 
tocotrienols, all of which have Vitamin E activity, became apparent in the 1990’s and its 
role in cardiovascular medicine is now eminently obvious. In general, it helps remedy all 
degenerative diseases either directly, indirectly or in combination with good diet. 
 
 In spite of all these developments, Vitamin E’s mechanism of scavenging reactive 
oxygen species (ROS) is not fully understood.  The term ROS includes everything from 
singlet oxygen via superoxide anion and hydrogen peroxide, all the way to hydroxyl 
radical.  Yet, it remains to be seen what the role of Vitamin E is in the multifaceted 
reactions of ROS. 
 
 The present dissertation will concentrate on the various congeners of tocopherol 
and tocotrienol models. Since the electron density distribution of all the various 
congeners containing O, S and Se are different. Therefore, they will have different 
chemical reactivity.  It is not unreasonable to expect that these different chemical 
reactivities may well predetermine the anti-oxidant activities of Tocopherol congeners, 
isomers and conformers. A combined putative mechanism of action of the redox activity 
of tocopherols and tocotrienols is reported here in detail. 
 
 Not all aspects of Vitamin E are investigated in this research. The present 
dissertation represents a 'progress report' on the molecular structure of Vitamin E model 
compounds. Thus, this dissertation may have raised more questions than answers. 
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1. PREAMBLE 
 
1.1 Predicaments 
 
The following quote1 summarizes the future predicaments in the USA. Clearly, the situation 
is expected to be analogous to the entire Western World or perhaps to the entire Human 
Race. 
 
"It is rare to see a day pass in which we are not told through some popular 
medium that the population is becoming older. Along with this information 
comes the 'new' revelation that as we enter the next millennium there will be 
increases in age-associated diseases (e.g., cancer, cardiovascular disease) 
including the most devastating of these, which involve the nervous system 
(e.g., Alzheimer's disease [AD] and Parkinson's Disease[PD]). It is estimated 
that within the next 50 years approximately 30% of the population will be 
aged 65 years or older. Of those between 75 and 84 years of age, 6 million 
will exhibit some form of AD symptoms, and of those older than 85 years, over 
12 million will have some form of dementia associated with AD. What appears 
more ominous is that many cognitive changes occur even in the absence of 
specific age-related neurodegenerative diseases. Common components 
thought to contribute to the manifestation of these disorders and normal age-
related declines in brain performance are increased susceptibility to long-
term effects of oxidative stress (OS) and inflammatory insults. Unless some 
means is found to reduce these age-related decrements in neuronal function, 
health care costs will continue to rise exponentially. Thus, it is extremely 
important to explore methods to retard or reverse age-related neuronal 
deficits as well as their subsequent, behavioural manifestations. Fortunately, 
the growth of knowledge in the biochemistry of cell viability has opened new 
avenues of research focused at identifying new therapeutic agents that could 
potentially disrupt the perpetual cycle of events involved in the decrements 
associated with these detrimental processes. In this regard, a new role in 
which certain dietary components may play important roles in alleviating 
certain disorders are beginning to receive increased attention, in particular 
those involving phytochemicals found in fruits and vegetables."  
    
Undoubtedly, the situation that is now at hand will  intensify in the future. 
 
 
1.2 The Economic Burden of Illness 
 
Besides creating human suffering, illness is also a source of an economic burden. This is true, 
irrespectively of whether one has a national healthcare system or the cost of medical care 
falls on the shoulders of individuals. 
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Sometime, where the economic burden becomes unbearably drastic, measures are taken. In 
an individual case, it may mean not seeking the help of medical doctors, as the family may be 
unable finance it. In the case of a national healthcare system, extra tax is levied either 
universally or in the form of “user fees”. 
 
Table 1 shows the Canadian Scenario as it was in 1993. About 40% of the national budget 
was spent on degenerative diseases (Table 1) of which more than 20% was related to 
cardiovascular cases. An educated guess suggested that a possible cut of these expenses to 
about a half may be possible with the tools of “Preventive Medicine” utilizing dietary 
supplements in which Vitamin E plays a significant role. 
 
Table 1 - Costs of Degenerative Diseases in Canada during 1993 
 
      Billion $ Percentage 
Cardiovascular 
Coronary     30.294  23.447% 
Stroke 
Cancer     14.341  11.100% 
Alzheimer's        
Parkinson's (approximately)   7.045  5.453%         
Degenerative Diseases   51.680  40.000% 
All other Medical Expenses  77.520  60.000% 
Total for 1993      129.200 100.000%  
     
 
 
 
Degenerative Diseases   25.840  20.000% 
All other Medical Expenses  77.520  60.000% 
 
Total Predicted    103.360 80.000% 
 
In closing, it might be mentioned that the cost of a heart transplant in the 1990’s was about 
US$250,000 and in 1999, the USA performed 2184 heart transplants (US $546 million). In 
contrast, to that dietary supplements could reduce the severe cardiovascular cases 
dramatically for approximately US$1.00 per day/person. 
 
1.3 The Nature of Oxidative Stress 
 
Since chemical reactions are usually not quantitative, up to 5% of the oxygen we are inhaling 
is converted to "reactive oxygen species" (or ROS for short). During the normal metabolism 
while the food is oxidized in the living cells, oxygen is also being reduced to water. The 
reduction is a multi-step process, and the intermediate stages are these ROS. 
 
O2  →  O2.- →  HO-O. →  H2O2 → ....... →  HO. → .........→ H2O (1) 
 
Possible to cut in half 
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When any of these ROS escapes from this sequence of reductive reactions, they damage the 
structure of the cell, including the DNA, the RNA, proteins, as well as cell membranes. Such 
damages also lead to degenerative diseases, as well as a weaker immune system. 
 
Considering that in every human being these ROS strike and fracture every single one of the 
DNA molecules 10,000 times a day. About 9,900 of these breaks in the DNA strands are 
restored by DNA repair enzymes. About 100, or 1%, escape the enzymes’ activity. These 
unrepaired damages, accumulated over time, set the stage for atherosclerosis, cancer and 
other degenerative diseases. It is clear that slowing the damage – by increasing antioxidant 
protection – translates directly into a healthier and longer life span. 
 
The body has two types of mechanisms to eliminate these ROS before they can make 
significant damage. These include the following: 
 
i)  Enzymatic reductions, beyond the regular process 
ii)  Scavenging these ROS by antioxidant compounds naturally 
 supplied by a healthy diet 
 
Both of these mechanisms fight a losing battle against ROS with advanced age. However 
even at a younger age the ammunition for these mechanisms must come from a healthy diet, 
which is not always available. In such a case, the 'healthy diet' does include dietary 
supplement. Needless to say, for long term benefits it is important that young people acquire, 
as early as possible, an attitude which is pro 'healthy diet'. 
 
 
1.4 Essential Nutrient Components 
 
Both of the above two mechanisms to fight ROS require certain special nutrients.  
 
For Mechanism (i), it may be some trace element such as Magnesium, Vanadium, 
Chromium, Manganese, Iron, Copper, Zinc or Selenium (Mg, V, Cr, Mn, Fe, Cu, Zn, or Se), 
that may be essential at the active site of a particular enzyme. If these trace elements are not 
available, Mechanism (i) will not be operative. For example, the natural selenium (Se) level 
in the soil is highly variable. In the USA, the Eastern Coastal Plain and the Pacific Northwest 
have the lowest levels of Se. In these areas, the daily Se intake of the population is in the 
range of 60 to 90 micrograms (µg). In contrast, in the Se rich areas, the range of daily Se 
intake is 60 to 200µg. The average daily US intake is 125µg. People living where the highest 
levels of Se exist have the lowest levels of lung, colon, bladder, pancreas, breast and ovarian 
cancers. Clearly, if the soil is depleted of Se, the vegetation cannot have enough and 
therefore, the local diet would have insufficient amounts of Se. It is stipulated that the daily 
intake should be in the vicinity of 300µg. It may well be that the diet of the whole North 
American continent is too low in Se. This may be responsible for some of the high levels of 
degenerative ailments, such as cancer and cardiovascular diseases. Of course, an overdose of 
Se is dangerous, however this is not expected to happen before the daily intake 
reaches1000µg. 
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Figure 1 shows the putative mechanism of Glutathione Peroxidase in a schematic fashion. 
E-Se(-) symbolizes the selenium deprotonated enzyme. This enzyme only catalyzes the 
overall reaction of hydrogen peroxide decomposition, since it is not consumed during the 
reaction but is in fact recovered unchanged. The stoichiometry of the reaction involving 
hydrogen peroxide and reduced glutathione (GSH) is as follows:  
 
H2O2 + 2GSH → 2H2O + G-S-S-G  (2) 
 
Of course, the selenium deprotonated enzyme, E-Se(-), has a deprotonated selenocysteine 
(Sec) residue at its active site. This Selenocysteine sometimes is called the 21st amino acid 
because it can be incorporated in a protein. However, it only has an RNA codon but no DNA 
codon. 
 
The other important enzyme is superoxide dismutase (SOD) which converts the highly 
dangerous (reactive, oxidizing) superoxide (O2-) to the not so dangerous H2O2. The enzyme 
structure contains Zn and Cu ions. 
 
2O2- + 2H+ → H2O2 + O2 (3) 
 
The H2O2 thus formed is further reduced to H2O with the help of glutathione peroxidase 
discussed above. 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Biochemical pathway of glutathione peroxidase (E-Se-) 
GSH
ROOH + H (+)
E-SeOH
Selenenic acid
GSHH2O
E-Se-S-G
Selenosulfide
GSSG + H (+)
ROH
E-Se (-) Selenolate
  5
For Mechanism (ii), certain vitamins (like C and E) as well as certain antioxidants such as 
lycopene, β-carotene, flavones, farnesol, allyl-methyl-disulfide, lipoic acid, coenzyme Q10 or 
ubiquinone, may also be required. Plants produce these antioxidants thus fruits and 
vegetables are expected to supply them. However, the level of these antioxidants in fruits and 
vegetables may vary according to the geographical location where they were produced, and 
could also vary from season to season, or even with distance of transportation. Consequently, 
for a healthy diet, the antioxidants may have to be added to the food items or must be 
provided as a supplement. If regular food was sufficiently nutritious, or if dietary 
supplements were included in meals, degenerative diseases may be reduced substantially, 
which in turn could considerably reduce health care costs. 
 
 
1.5 Diet and Dietary Supplements 
 
Ideally, the purpose would be to produce food products at accessible prices that will prevent, 
or at least forestall, the development of degenerative diseases such as cancer, heart attack, 
stroke, as well as Alzheimer and Parkinson's diseases. All of these ailments are due, to a 
great extent, to oxidative stresses. The presence of certain natural products, which may 
currently be inadequate in our daily diets, that if taken within the right range of 
concentrations can prevent, or at least forestall the development of such ailments. In addition, 
to reduce the risk of such degenerative diseases, some of these natural products can 
strengthen the immune system leading to fewer viral or bacterial infections. The loss of fewer 
workdays may be expected due to the reduction of illness and infection. In general, with 
proper diet our entire society could become healthier, stronger, and less vulnerable to 
degenerative diseases. In the absence of a perfect diet, dietary supplements must be 
considered. 
 
However, the suggested dosage does change from one medical condition or another as shown 
in Table 2. Also, Table 3 shows the RDA (recommended daily allowance) and ODA 
(optimum daily allowance). For a defensive strategy within the field of preventive medicine 
the ODA is sometimes more than an order of magnitude higher than the RDA. This is the 
case for Vitamin E; the RDA values range from 8-10mg and the ODA values are within 250-
1000mg or 400-1600IU.  
 
Table 2 - Suggested dosage of Vitamin E for various medical conditions 
Condition Suggested Dosage
Aging 400-800 IU
Cancer Prevention 400-800 IU
Cardiovascular disease prevention 400-800 IU
Diabetes 800-1600 IU
Fbrocystic breast disease 800-1600 IU
Menopausal "hot flashes" 800-1600 IU
Poor circulation 800-1600 IU
Prementrual syndrome 800-1600 IU
Prevention of excessive bleeding with IUDs 100-400 IU
Wound healing 400-800 IU
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Table 3 – Recommended (RDA) and Optimum (ODA) Daily Allowance for Minerals and 
Vitamins 
 
The natural abundance of these 2x4=8 components of the Vitamin E family varies from plant 
to plant [2]. Table 4 illustrates some natural abundances. 
 
Table 4 – Typical Vitamin E content of selected foods (based on α-tocopherol activity) 
 Vitamin E  
 mg/100g food portion IU/100g food portion 
Wheat germ oil 119 178 
Sunflower oil 49 73 
Peanut oil 19 28 
Soybean oil 8.1 12 
Butter 2.2 3.2 
Sunflower seeds, raw 50 74 
Almonds 27 41 
Peanuts, dry roasted 7.4 11 
Asparagus, fresh 1.8 2.7 
Spinach, fresh 1.8 2.7 
1 mg α-tocopherol equivalent to 1.49 IU. 
NUTRIENT RDA (Men) RDA (Women) ODA
Minerals
Boron  none  none  1-3mg 
Calcium  800 mg.  800 mg.  1,000-2,000 mg. 
Chromium  50-300 mcg.  50-200 mcg.  100-600 mcg. 
Copper  1.5-3 mg.  1.5-3 mg.  1-3 mg. 
Iodine  150 mcg.  150 mcg.  225 mcg. 
Iron  10 mg.  15 mg.  0-40 mg. 
Magnes ium  350 mg.  280 mg.  500-1,000 mg. 
Manganese  2-5 mg.  2-5 mg.  5-15 mg. 
Molybdenum  75-250 mcg.  75-250 mcg.  75-250 mcg. 
Potass ium  none  none  100-500 mg. 
Selenium  70 mcg.  55 mcg.  100-300 mg. 
Vanadium  none  none  25-100 mcg. 
Zinc  15 mg.  12 mg.  15-50 mg. 
Vitamins
A  1,000 mcg. (5,000 IU)  800 mcg. (4,000 IU)  1,000-10,000 IU 
Thiamin (B1)  1.5 mg.  1.1 mg.  100-250 mg. 
Riboflavin (B2)  1.7 mg.  1.3 mg.  50-250 mg. 
Niacin/niacinamide (B3)  19 mg.  15 mg.  50-250 mg. 
Pantothenic acid (B5)  4-7 mg.  4-7 mg.  60-2,000 mg. 
B6 (pyridoxine)  2 mg.  1.6 mg.  25-250 mg. 
B12 (cobalamine)  2 mcg.  2 mcg.  500-2,000 mcg. 
Folic Acid  200 mcg.  180 mcg.  800-2,000 mcg. 
Lycopene  5 mg.  5 mg.  15-30 mg. 
Beta-carotene  none  none  25,000-100,000 IU 
Biotin  30-100 mcg.  30-100 mcg.  200-800 mcg. 
C  60 mg.  60 mg.  675-3,000 mg. 
D  5 mcg. (200 IU)  5 mcg. (200 IU)  200-1,000 IU 
E  10 mg. (15 IU) *  8 mg. (12 IU) *  400-1,600 IU ** 
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1.6 The role of Vitamin E in Cardiovascular Diseases as an Oxidative Protector of LDL 
 
Lipids travel from the small intestine all through the bloodstream to every cell to be used as 
fuel. They are ‘packaged’ and ‘repackaged’ along the way. Each of the phases produces 
aggregates with varying degree of cholesterol content, which are globular micellelike 
particles. 
 
Lipoprotein densities increase with decreasing particle diameter, since the density of their 
outer coating is greater than that of their inner core. Thus, the HDL, which are the most dense 
of the lipoproteins are also the smallest. Five distinctly different molecular aggregates exist 
(Table 5) and their inter-conversion scheme is as follows: 
 
Chylomicrons => VLDL => IDL => LDL => HDL  (4) 
 
The protein components of lipoproteins are known as apolipoproteins or just apoproteins. At 
least nine apolipoproteins are distributed in different amounts in the human lipoproteins 
(Table 5). They form roughly a 20Å mono-layer wrapped around the surface as shown in 
Figure 2. Most of the apolipoproteins are water soluble and associate rather weakly with 
lipoproteins. These apolipoproteins have a high helix content which increases when they are 
incorporated into lipoproteins. Apparently, the helices are stabilized by a lipid environment, 
because helices fully satisfy the backbone’s hydrogen bonding potential in the lipoprotein’s 
water-free interior 
 
Very often HDL is labelled as “good cholesterol” and LDL as “bad cholesterol”. Actually 
this is a misnomer as there is no “good” nor “bad” cholesterol. The reason for such 
designation comes from the fact that LDL is more susceptible for oxidation than the other 
forms. Thus the oxidative stress converts LDL to oxidized LDL, responsible for plaque 
formation, the source of all cardiovascular problems. Vitamin E, by virtue of the fact that it is 
lipid soluble, is accumulated in these lipoproteins. It should be noted that the higher the daily 
Vitamin E intake, the higher its concentration in lipoprotein. 
 
In the August 7, 1997, issue of the New England Journal of Medicine, Marco Diaz, MD, 
wrote a review article2 entitled, “Antioxidants and Atherosclerotic Heart Disease.” He 
concludes that antioxidants may very well reduce the risk of atherosclerosis by helping 
produce LDL resistance to oxidative modification and thus, reduce inflammation of the 
artery and the initial phase of atherosclerosis (the fatty streak). He goes on to state there may 
be other mechanisms by which antioxidants help reduce the risk of nonfatal heart attacks. 
This is probably by stabilizing the plaque where it is most likely to rupture, which is in the 
oxidized, LDL-laden, foam cell layer of the plaque. It may also reduce the size of the plaque. 
This means even individuals who have significantly advanced hardening of the arteries 
would benefit from supplementation with antioxidants such as Vitamin E. 
  8
 
Table 5: Characteristics of the Major Classes of Lipoproteins in Human Plasma 
Chylomicrons VLDL IDL LDL HDL
Density (g*cm-3) <0.95 <1.006 1.006-1.019 1.019-1.063 1.063-1.210
Particle diameter (Å) 750-12,000 300-800 250-350 180-250 50-120
Particle mass (kD) 400,000 10,000-80,000 5,000-10,000 2,300 175-360
% Proteina 1.5-2.5 5-10 15-20 20-25 40-55
% Phospholipidsa 7-9 15-20 22 15-20 20-35
% Free cholesterola 1-3 5-10 8 7-10 3-4
% Triacylglcerolsb 84-89 50-65 22 7-10 3-5
% Cholesteryl estersb 3-5 10-15 30 35-40 12
Major apolipoproteins A-I, A-II, B-48, C-I, C-II, C-III, E
B-100, C-I, C-II, 
C-III, E B-100, C-III, E B-100
A-I, A-II, C-I, C-
II, C-III, D, E
a Surface Components b Core Lipids
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Diagram of LDL, the major cholesterol carrier of the bloodstream. This spheroidal 
particle consists of some 1500 cholesteryl ester molecules surrounded by an amphiphilic coat 
of ~800 phospholipid molecules, ~500 cholesterol molecules and a single 550-kD molecule 
of apolipoprotein B-100. 
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2. CHOICE OF TOPIC 
 
Vitamin E, a term introduced3 in 1922, does not represent a single compound but in fact 
includes two families of compounds: tocopherols and tocotrienols4.  Both families consists of 
a chroman [benzpyran] ring structure and a sidechain.  The sidechain has the characteristics, 
isoprenoid skeleton, typical of terpenes.  Members of the tocopherol families have saturated 
sidechains but the same sidechain in the tocotrienol family has three non-conjugated double 
bonds.  Such carbon – carbon double bonds are separated by –CH2 –CH2- units.  For both 
families the carbon atom that carries the sidechain is stereo centre of R configuration; 
however the sidechain of the tocopherols have two additional stereo-centres at the branching 
points, both of which are of R configuration.  The structural variations of the two families are 
shown in Figure 3 and Figure 4. 
 
 
 
 
 
O
CH3
R2
R3
HO
R1
H3C H3C H3C
CH3
 
Figure 3 – The Structure of Tocopherol in R configuration 
 
 
 
 
O
CH3
R2
R3
HO
R1
H3C H3C H3C
CH3
 
Figure 4 – The Structure of Tocotrienol 
 
 
 
Each of these families has four homologous members, labelled as α, β, γ, and δ.  They differ 
from each other in the extent of methyl substitution in the aromatic ring (R1, R2, R3). 
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Table 6 - Methyl substituted homologues of Tocopherol and Tocotrienol 
 
 R1 R2 R3 
α Me Me Me 
β Me H Me 
γ H Me Me 
δ H H Me 
 
Thus these are two (2) families of compounds (tocopherol and tocotrienol) and each may 
come in four (4) homologous forms. 
 
Of these 2x4=8 species, it is α–tocopherol which is most frequently used, partly due to the 
fact that it is commercially available in synthetic form. Of course the synthetic form is not a 
pure enantiomer but is instead a mixture of R- and Sα- tocopherol acetate (see Table 7 and 
Figure 5). The effectiveness of the synthetic form has been traditionally questioned with no 
explanation at the molecular level, even though the primary function of Vitamin E is an 
antioxidant then undergoing an oxidation reaction at the molecular level. We now have more 
precise data to support the earlier assumption5. 
 
Table 7 - Natural and synthetic compounds of the Vitamin E family 
 
Natural derivatives Activity %
RRR-α-tocopherol 100 
RRR-β-tocopherol 57 
RRR-γ-tocopherol 37 
RRR-δ-tocopherol 1.4 
R- α –Tocotrienol 30 
R-β-tocotrienol 5 
Synthetic derivatives Activity %
RRR- α –tocopheryl acetate 100 
RRS- α –tocopheryl acetate 90 
RSS- α –tocopheryl acetate 73 
SSS- α -tocopheryl acetate 60 
RSR- α –tocopheryl acetate 57 
SRS- α –tocopheryl acetate 37 
SRR- α –tocopheryl acetate 31 
SSR- α –tocopheryl acetate 21 
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Figure 5 - Stereoisomers of tocopherols 
 
Recently it has been suggested6 that the selenium congener of α–tocopherol (Figure 6) may 
be a very effective antioxidant. 
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CH3
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CH3
HO
R1
H3C H3C H3C
CH3
 
 
Figure 6 - The Structure of Seleno-tocopherol 
 
This raises the question of whether the sulphur (S) and selenium (Se) congeners of Vitamin E 
may be more effective antioxidants than Vitamin E itself. The answer to such a question may 
be decided by quantitatively characterizing the redox mechanism of the three congeners 
containing O, S and Se, respectively. 
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3. INTRODUCTION 
 
3.1 The Consequences of Oxidative Stress 
 
One of the major current theories of aging as well as of the origin of numerous degenerative 
diseases is associated with a variety of free radical reactions within the human body7. These 
reactions are collectively referred to as oxidative stress. 
The free radicals are generated as by-products of redox reactions associated with the 
metabolism8. The free radicals include the superoxide anion (O2-), the hydroperoxyl radical 
(HOO), hydrogen peroxide (H2O2) and the hydroxyl radical (HO). These are collectively 
referred to as "reactive oxygen species" (ROS). They are all very reactive in the body and 
therefore short-lived. Normally there are natural mechanisms defending against the free 
radicals within the body9, which may be enzymatic or non-enzymatic. However, if for some 
reason, these defence mechanisms become weakened, then the free radicals can react with 
cellular structures like DNA as well as proteins or destroy membranes through lipid 
peroxidation10,11,12. It is generally believed that through these processes, aging and other age 
related degenerative diseases such as cardiovascular disorders and cancer, are induced7. 
Recently, oxidation of a methionine residue, as a result of oxidative stress has been 
implicated13 in the initiation of Alzheimer disease. 
 
Vitamin E is a potent antioxidant that helps prevent cancer by blocking lipid peroxidation; 
the oxidation of polyunsaturated fats into free radicals. Lipid peroxidation is potentially 
important in all cancers but is especially significant as a cause of breast and colon cancers. 
 
Vitamin E also serves a crucial role in immune system function. A low level of the vitamin 
leads to impaired antibody production, the inability to manufacture T and B lymphocytes and 
reduced resistance to cancer and infection. 
 
Vitamin E works synergistically with Vitamin C and the mineral selenium (Se), with which it 
has a special affinity. Selenium and Vitamin E combined, constitute a ‘one-two punch’ 
against cancer. Since it is not possible to obtain optimally protective quantities of Vitamin E 
from diet alone, supplements of 400 to 1,600 international units daily are recommended. 
 
 
3.2 Structural Background 
 
One of the structural problems of the compounds and their basis of activity is associated with 
the saturated heterocyclic ring fused to the benzene ring.  This ring cannot be considered to 
be cyclohexane or its heterocyclic analogue in a boat or chair conformation since it has, at 
least formally, one carbon-carbon double bond. 
 
The so-called “half-chair” conformation had been considered to be the most likely structure, 
before experimental observation provided strong support for that assumption. 
 
The ring is expected to exist in to two interconvertible enantiomeric forms. The transition 
state for such a ring-flip is expected to show some symmetry. It is tempting to consider the 
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planar structure to be a good candidate for the transition state but such a conformation could 
be a higher order critical point. It is more likely that the transition state is a boat 
conformation. (Figure 7) 
 
 
O O
O
 
Figure 7 - Ring flip in dihydropyran 
 
 
Tetralin may be regarded as the hydrocarbon analogue of such a heterocyclic ring. Of the 
four CH2 groups in tetralin, the two allylic CH2 exhibit quasiaxial or pseudoaxial (a′) and, 
quasi-equatorial or pseudo-equatorial (e′) orientation while the orientation of the central CH2-
CH2 moiety is expected to be close to non-cyclic molecules such as ethane or butane. This is 
illustrated in the case of cyclohexene 14. (Figure 8) 
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Figure 8 - Conformation and dihedral angles of cyclohexene previously obtained on the 
basis of molecular modelling 
 
Thus, the further away we go from the double bond, the closer we get to the ideal situation. 
Estimated dihedral angles (Di) may look like the following. 
 
While we cannot extrapolate in a blindfolded way to the stereochemistry of the tetralin from 
the conformations of cyclohexene, nevertheless some analogy is expected. 
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4. AIM OF STUDY 
 
In the first phase of the Project the structure of the chroman ring together with its S and Se 
congeners were studied. Naturally, one may wish to compare chroman with its hydrocarbon 
analog (tetralin).   Tetralin(I), chroman(II) and its sulphur(III) and selenium(IV) congeners 
are shown below. (Figure 9) 
 
Column IIa   Column VIa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Tetralin as well as chroman and its congeners, with their respective Groups in the 
periodic table. 
 
In the second phase of the project, the conformational intricacy of a shortened model of α-
tocopherol has been investigated. 
 
In the third phase, the stabilization or destabilization effect of the subsequent methyl 
substitution on the benzene rings has been investigated with special emphasis on the α, β, γ 
and δ-tocopherol models. 
 
In the fourth phase, an oxidative mechanistic study has been carried out on α-tocopherol, as 
well as α-thiotocopherol and α-selenotocopherol models to some extent. 
 
The corresponding models are depicted in Figure 10. 
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5. METHOD 
 
5.1 Computational Background 
 
Since it is generally believed that the tail ends of tocopherols are only needed to enhance fat 
solubility15, it is appropriate to concentrate on the fused ring systems. 
 
Due to the large size of tocopherols (C28H50O2) and current limitations of computational 
resources, only model compounds were studied.  The size of the various models investigated 
are shown below (Figure 10) with respect to the full tocopherol structure. Computations 
were carried out using the Gaussian 98 program16  “package”. 
 
X
CH3
R2
R3
HO
R1
H3C
Model A
Model B
Model C
Model D
Model E
 
 
Figure 10 – Models of tocopherols 
 
The structural stabilities were investigated on going from Model A through Model E. The 
redox mechanism was investigated in the case of the α-tocopherol model (Model E). 
 
Convergence criteria of 3.0x10-4, 4.5x10-4, 1.2x10-3, and 1.8x10-3 were used for the gradients 
of the RMS (root mean square) Force, Maximum Force, RMS Displacement and Maximum 
Displacement vectors, respectively. 
 
Although computations have been carried out at several levels of theory, only the results 
obtained at the highest level [B3LYP/6-31G(d)] are reported in this dissertation. 
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5.2 Models A and B 
 
Molecular computations were carried out on the following four compounds:  tetralin (I), 
chroman (II), thiochroman (III), and selenochroman (IV) as shown in Figure 11. No 
visualization tool was used for this purpose. 
 
For the sake of convenience, the variations of geometrical and energetic parameters from O 
to S to Se were fitted to quadratic functions, even though no quadratic relationships are 
assumed to be operative. For such graphical presentation the optimized parameters were 
plotted against the covalent atomic radii: O = 0.745Å, S = 1.040Å and Se = 1.163Å 15, 16. 
 
 
5.3 Models C and D 
 
Corresponding to Model A through Model D, four families (A, B, C, D) of the four 
compounds (I, II, III, IV) were studied as shown in Figure 4.  Altogether, sixteen 
compounds were studied. Compound III and IV are sulphur and selenium congeners of II. 
 
No visualization tool was used for any computational purpose of this work.  It should be 
noted that there are two extra hydrogen atoms in the carbon congeners (i.e. X=CH2) of IA, 
IB, IC and ID.  Key dihedral angles are defined in Figure 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 - Definition of key dihedral angles. 
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In order to compare the relative stabilities of the X=O, S and Se congeners, the following 
three isodesmic reactions were applied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The overall stabilization energy is the sum of the two individual stabilization energies. 
 
 
For the sake of convenience, the variations of geometrical and energetic parameters from O 
to S and Se were fit to quadratic functions, even though no quadratic relationships are 
assumed to be operative.  For such graphical presentation the optimized parameters were 
plotted against the covalent atomic radii:  O = 0.745Å, S = 1.040Å and Se = 1.163Å 17, 18.  
 
 
5.4 Model E 
 
Eight structures, the unsubstituted and seven methyl substituted ring structures, were 
considered for oxygen (II), sulphur (III), and selenium (IV) heteroatoms in the ring.  Thus, a 
total of 3x8=24 structures are reported on this model E.  Of the seven substituted structures 
four are Vitamin E models (α, β, γ, δ while the remaining three (E, E*, F), two single (E, E*) 
and one double (F) methylated ring respectively, have no relation to Vitamin E. 
 
The stabilization or destabilization exerted by the methyl groups attached to the aromatic ring 
were studied through isodesmic reactions in which the Me group was transferred from 
toluene to the aromatic ring of the chroman skeleton, as well as its sulphur and selenium 
congeners.  The following B3LYP/6-31G(d) energy values were used for toluene and 
benzene: (-271.56662) and (-232.248659) hartrees respectively. 
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5.5 Redox Reaction Mechanisms 
 
The definition of the spatial orientation as well as the numbering of the constituent atomic 
nuclei are shown in Figure 3.  The input files were numerically generated.  No visualization 
tool was used for this purpose.   Abinitio Molecular orbital  calculations, completed using the 
Gaussian as program package calculations are reported at the B3LYP/6-31G(d) levels of 
theory. 
 
For the hydride abstraction, three different cations were investigated correspondingly to mild, 
medium and strong hydride affinity.  The computed energies necessary for balanced 
reactions are summarized in Table 8.  On the basis of the computed hydride affinities 
(Table 8) it seems that the H(-) affinity of pyridinium ion is numerically close to that of Li(+).  
For this reason, rather then NADH, Li-H may be used as a hydride donor in its place at least 
on energetic grounds  The computed total energies for both radical and ionic reactions are 
listed in Table 9. 
 
 
 
Table 8 - Energy Components and hydride affinities for hydride abstraction as computed at 
the B3LYP/6-31G(d) level of theory 
 
Cation E(Hartree) Neutral E(Hartree)
Hydride Affinity 
(Kcal/mol)
Li(+) -7.284544 LiH -8.081922 210.57
C5H6N(+) -248.656978 C5H7N -249.455315 211.17
CH3(+) -39.480388 CH4 -40.518383 361.56  
 
 
 
Table 9 - Energy Components, necessary to balance the redox reactions, computed at the 
B3LYP/6-31G(d) level of theory 
 
Species E(Hartree) Species E(Hartree)
E(H-) -0.461817 E(HOO·) -150.899156
E(HO·) -75.723455 E(HOO-) -150.462597
E(H2O) -76.408953 E(HOOH) -151.532085
E(H3O
+) -76.685908 E(HOOLi) -158.503570
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6. RESULTS AND DISCUSSION 
 
6.1 Molecular Structures 
 
One of the structural problems of Vitamin E is associated with the saturated ring fused 
to the benzene ring.  This ring cannot be considered to be cyclohexane, nor any of its 
heterocyclic analogues in the chair conformation, because it has, at least formally, one 
carbon-carbon double bond.  The so-called “half-chair” conformation had been 
considered to be the most likely structure and was confirmed by experiment14, 19-24. 
 
Of the four CH2 groups found in tetralin, the two allylic CH2 groups exhibit quasiaxial 
or pseudoaxial (a′) and quasi-equatorial or pseudo-equatorial (e′) orientations.  The 
orientation of the central CH2-CH2 moiety is expected to be close to non-cyclic 
molecules such as ethane or butane.  Thus, the further one moves away from the double 
bond, the closer one comes to the ideal situation.  Optimized dihedral angles (Di) are 
shown in Table 10. 
 
Table 10 – Previously reported and presently optimized dihedral angles of 
cyclohexene, computed at the B3LYP/6-31G(d) level of theory 
 Dihedrals * Previously Reported Present Optimized
D1 0.00 -1.61 
D2 -15.20 -13.87 
D3 44.20 44.11 
D4 -60.20 -60.47 
D5 44.20 44.14 
D6 -15.20 -13.90 
* as defined in Figure 8 
 
The ring is expected to exist in two inter-convertible enantiomeric forms with the 
transition state for such a ring-flip expected to show some molecular symmetry; 
interconnecting the two non-super-imposable mirror image (enantiomer) minima on 
either side.  It is tempting to consider the planar structure to be a good candidate for the 
transition state, but such a conformation could be a higher order critical point.  It is 
more likely that the transition state is a boat conformation.  The ring-inversion has been 
studied computationally only in the cases of tetralin as well as its oxygen, sulphur and 
selenium congeners25. 
 
6.1.1 Ring Conformations of Vitamin E models (Models A and B) 
 
The optimized bond lengths show no deviations from expected structural behaviour.  
The greatest change is expected in the C-X-C region. The C-X bond length, involving 
the aromatic carbon is slightly shorter than the other one, involving the aliphatic 
carbon. These optimized bond lengths correlate linearly with the covalent radii of O, S 
and Se. 
 
4
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D2 D3
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D1 D4
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The C-X-C and the X-C-C bond-angles are of greatest interest as X is changed from O 
to S and Se.  Values show that the C-X-C bond-angle is undergoing the greatest change, 
as O is changed to S and Se, the C-X-C bond-angle moves from a value larger than 
tetrahedral towards 90°, typical of S and Se.  In contrast to this, the X-C-C bond-angle 
is compensating for such a dramatic closing in C-X-C, through a modest opening in the 
X-C-C values.  These changes at the DFT level are evaluated as moving from 111.8º, 
for (X = Oxygen) to 113.5º (X = Selenium). 
 
For the torsion of the heterocyclic ring, dihedral angles behave in an interesting way. 
Some dihedral angle pairs behave in non-routine fashion, as if the influence of the X 
nucleus on these two dihedrals was inconsequential.  Other dihedral angles are similar 
in magnitude while others are nearly identical. 
 
6.1.1.1 Molecular geometries at transition structures 
 
The ring inversion (Figure 7) was studied in the cases of compounds I, II, III and IV.  
For compound II (X = Oxygen) the initial state, the transition state and the final states 
are shown in Figure 12.  Clearly the fused heterocyclic ring exhibits a highly distorted 
boat arrangement (Figure 12) in comparison to the idealized case given in Figure 7.  
 
 
 
 
 
a) 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
c) 
 
 
 
 
Figure 12 - Optimized minimum energy (a, c) and transition (b) structures for chroman 
(X=O). The sulphur (X=S) and selenium (X=Se) congeners have 
analogous geometries. 
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6.1.1.2 Energetics of Ring inversion 
 
The energies of activations (Ea) values for the X = [O, S, Se] containing molecules (II, 
III and IV, respectively) were plotted against the covalent radii of X.  The difference 
between O and S is large while the difference between S and Se is small. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 – Variation of ring inversion energy of activation with the size of the 
heteroatom 
 
The left hand side plot shows a quadratic fit while the right hand side plot shows an 
exponential fit  only after it was determined that the exponential function converges to 
2.78 Kcal·mol-1. 
 
6.1.2 Ring Substitutions of Vitamin E models (Models C and D) 
 
6.1.2.1 Molecular Geometry of Stable Structures 
 
The geometry exhibited changes with heteroatom substitution.  The increasing atomic 
size created by the progression from oxygen to sulphur, then to selenium made a 
noticeable difference for selected bond length, bond angles and dihedral angles. 
 
Changes in C-C bond lengths and bond angles about a carbon atom are influenced 
slightly by the nearby O, S or Se.  However, the changes are not large and their change 
is not necessarily monotonic, as one would expect on the basis of the periodic table  
(O ? S ? Se).  Very often the parameter in question for sulphur is either smaller or 
larger than that for the oxygen and selenium-containing compound. 
 
Take for example the bond angle between the three saturated carbon atoms C-C-C* 
(where C* is the stereocentre) in Model D the following non-monotonic change was 
observed. 
 
112.1º ? 111.6º ? 112.4º   (9) 
O ?     S ?    Se 
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On going from the single heterocyclic ring (A) to the next larger system where a 
benzene ring is fused to the heterocycle (B), large amplifications in dihedral angles 
were noticed. This amplification was followed by two consecutive attenuations on 
going from B to C and subsequently, from C to D.  The  final system (D) did not differ 
much from the original (A) ring structure. 
 
 
6.1.2.2 Molecular Energetics 
 
The computed total energies are not comparable since each of the sixteen molecular 
systems has a different number of electrons. In order to make an energetic comparison 
of the sixteen molecular structures, some isodesmic reaction energy calculation should 
be made in order to determine the relative stabilization or destabilization exerted by the 
substituents on the basic structures.  The calculations were carried out according to 
equations given in the Method Section: (3) – (6). Stabilization energies are summarized 
in Table 6. 
 
Table 11 – Computed stabilization energies resulting from sequential substitution, 
computed at the B3LYP/6-31G(d) 
 
 
 
 
 
 
IB IB ? IC X IC ? XC  XC ? XD Total O ? X 
0.00 0.344 O -6.412  1.592 -4.820 0.000 
  S 0.428  0.759 +1.188 6.008 
  Se -5.293  0.566 -4.726 0.094 
 
The stabilization energies reveal that oxygen and selenium substitutions stabilize the 
ring system more or less to the same extent; -4.8 and -4.7 Kcal·mol-1, respectively.  
However, sulphur destabilizes the same ring system marginally (+1.2 Kcal·mol-1) 
 
It is clear from the plot of ∆Etotal stabilization energy against the covalent radii that O and Se 
are similar but S is completely different. (Figure 14) 
 
 
 
Figure 14 – 
Variation of 
total 
stabilization 
energy with C-
X bond length 
(X=O, S, Se) 
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6.1.3 Aromatic Methyl Substitution of Vitamin E models (Models E) 
 
6.1.3.1 Molecular Geometries 
 
A total of twenty-four compounds were subjected to geometry optimizations.  Of that 
total, each of the oxygen, sulphur, and selenium containing rings each had 8 
homologues containing 0, 1, 2 and 3 methyl groups attached to the aromatic ring. 
 
The structures of the 8 homologues are shown in Figure 15. 
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Figure 15 - Isodesmic Reactions for the incorporation of aromatic methyl substituents. 
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The structures of the triple methylated aromatic ring (J(α)-homologues) for the O, S 
and Se congeners computed at the B3LYP/6-31G(d) level of theory, are shown in 
Figure 16.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 - Three optimized structures of the shortened sidechain model of the α-
tocopherol computed at the B3LYP/6-31G(d). X=O (top), X=S (middle), X=Se 
(bottom) 
 
The hydroxyl group (OH) was almost always coplanar with the aromatic ring (within 
± 3º ), deviating at most up to ± 7º as a result of the steric ‘congestion’ arising from the 
six-fold substitution on the benzene ring.  The orientation of the OH was such that it 
pointed away from the adjacent CH3 group, whenever the structure would permit. 
 
There were some structural trends, whereby the C-C bonds adjacent to the C carrying 
the Me substitution are lengthened, irrespective of heteroatom substitution.  In contrast, 
the bond angles changed extensively with heteroatom substitution, irrespective of Me 
substitution.  Several other structural trends of smaller magnitude are also apparent but 
not elaborated upon here. 
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6.1.3.2 Molecular Energetics 
 
The computed total energies are summarized in Table 12.  The energies of stabilization 
calculated according to the scheme given in Figure 15 are tabulated in Table 13.  The 
graphical representation of these results is shown in Figure 17. 
 
 
Table 12 – Total energies (Hartrees) computed for the 24 optimized structures 
computed at the B3LYP/6-31G(d) level of theory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 13 – Energy of stabilization associated with single or  
multiple methyl group transfers computed at the B3LYP/6-31G(d) level of theory 
II(X=O) III(X=S) IV(X=Se)
single step accumulated steps single step
accumulated 
steps single step
accumulated 
steps
XD->XE 1.043 1.043 1.520 1.520 1.576 1.576
XD->XE* -0.430 -0.430 -0.562 -0.562 -0.658 -0.658
XE->XF 0.161 1.204 0.090 1.610 0.007 1.583
XD->XG(δ) -0.320 -0.320 0.372 0.372 -1.028 -1.028
XG(δ)->XH(γ) 1.952 1.633 2.386 2.759 2.147 1.118
XG(δ)->XI(β) 1.100 0.781 1.684 2.056 1.676 0.648
XI(β)->XJ(α) 2.918 3.699 3.879 5.934 3.587 4.235  
II(O) III(S) IV(Se)
D -617.36422 -940.33278 -2941.52972
E -656.68052 -979.64832 -2980.84517
E* -656.68287 -979.65164 -2980.84873
F -695.99823 -1018.96614 -3020.16312
G(δ) -656.68269 -979.65015 -2980.84932
H(γ ) -695.99754 -1018.96431 -3020.16386
I(β) -695.99890 -1018.96543 -3020.16461
J(α) -735.31221 -1058.27721 -3059.47685
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Figure 17 - Computed stabilization energies, determined at the B3LYP/6-31G(d) level of theory. 
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The extent of the naturally occuring (α, β, γ, δ) tocopherol are shown below in 
Figure 18. 
 
 
 
 
 
 
 
 
 
Figure 18 – Aromatic methyl substitution of α, β, γ and δ tocopherol 
 
A comparison of the relative activity of z-tocopherols (z = α, β, γ, δ), as measured by 
ln{[Az]/[Αα]}, may be envisaged as a functional dependence using the calculated 
energy of stabilization (∆Ez) as an independent variable. 
 
ln {[Az]/[Aα]}=F(∆Ez) (10) 
 
The numerical values are given in Table 14. 
 
Table 14 – Relative biological activity of tocopherols and computed stabilization 
energy values of model compounds, determined at the B3LYP/6-31G(d) level of 
theory. 
 
 
 
 
 
 
 
 
* Activities were taken from Reference [3], also quoted in Table 3 of Reference [13] 
 
Plotting the above equation yielded graphs that suggested that there may exist an 
exponential relationship interconnecting either one, or both, of the paths shown below: 
 
δ ? γ ? α (11) 
 
δ ? β ? α (12) 
 
For this reason the relationship is converted to the following form: 
 
y = 1.0 - ln{[Az]/[Aα]}=f(∆∆Ez)=f(x) (13) 
 
where x=∆∆Ez=∆Eα-∆Ez 
X MeR
HO
Me
X MeR
HO
Me
Me
Me
δ α
β
γδ α1 Me 3 Me2 Me
Relative Activity * Computed Stabilization Energy
z-tocopherol [Az]/[Aα] ln{[Az]/[Aα]} 1-ln{[Az]/[Aα]} ∆Ez ∆∆Ez=∆Eα−∆Ez
α 1.000 0.000 0.000 3.698 0.000
β 0.570 -0.562 1.562 0.780 2.918
γ 0.370 -0.994 1.994 1.634 2.054
δ 0.014 -4.269 5.269 -0.318 4.016
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The exponential function obtained for the first (δ ? γ ? α) of these two paths is shown 
in Figure 19.  While the fit shown in Figure 19 was fairly good (R2=0.99), the other 
path (δ ? β ? α) did not allow a fit to a reasonably good exponential function.  With 
respect to the exponential fit obtained for the δ ? γ ? α path, it seemed that β was 
estimated to be less stable by 1.750 Kcal/mol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 - Modified relative activity of tocopherol vs relative stabilization energies of 
tocopherol model 
 
While we have no explicit structured explanation for this derivation, it should be 
pointed out that the two methyl groups in the β form are in para-position with respect 
to each other.  This would suggest that any electronic effects the Me-groups might exert 
on the aromatic ring would be cancelled, or nearly cancelled, by vectorial addition.  For 
this reason, all the dipole moments were computed, revealing a reduction in polarity 
when the two para Me groups were present. 
  
This data showed that homologous E, F, I(β), and J(α) have dipole moments less than 1 
debye due to partial cancellation of electronic effects while homologous D, E*, G(δ) 
and H(γ) have dipoles over 2 debye.  This is the case for all three congeners. Note that 
the J(α), I(β), H(γ), G(δ) homologues are Vitamin E compounds while D, E, E* and F 
homologues are not members of the Vitamin E family. 
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The question of arithmetical additivity in the stabilization or destabilization effects of 
these Me-groups on the chroman ring and its congeners has to be examined at least in 
passing.  The results are shown in Table 15. 
 
 
Table 15 – Energies of stabilizations calculated as a sum of components or through 
direct computations 
II(X=O) III(X=S) IV(X=Se)
Sum of 
Components
Directly 
Calculated
Sum of 
Components
Directly 
Calculated
Sum of 
Components
Directly 
Calculated
XE + XE* -> XF 0.613 1.205 0.958 1.613 0.918 1.581
XG(δ) + XE* -> XH(γ) -0.750 1.634 -0.190 3.758 -1.094 1.183
XG(δ) + XE -> XI(β) 0.723 0.780 1.892 2.055 0.548 0.712
XI(β) + XE* -> XJ(α) 0.350 3.698 1.494 5.933 -0.010 4.301
 
 
It appears that the stabilization energies are not additive, indicating that in addition to 
the electronic effects, steric ‘congestion’ occurs when the methyl groups are proximally 
introduced.  Such an observation has been noted by Hammett [16] in studying chemical 
reactivity.  When the substituents were far away from the reaction site, good correlation 
was observed between reactivity and structure.  Alternatively, when substituents were 
placed in an ortho-position, the points scattered randomly and did not correlate at all.  
Thus, the Hammett linear free-energy relationship is valid only when the substituents 
are far away from the reaction site. 
 
For the I(β) isomers, where the two Me-groups are in para-position with respect to each 
other, the discrepancy is within 0.2 Kcal*mol-1.  For the F isomers, where the Me 
groups are in meta-position with respect to each other, the discrepancy is within 0.7 
Kcal/mol-1.  In these two cases the Me groups are virtually independent of each other.  
However, when two Me groups are in an ortho-orientation, the discrepancy is 4.3 
Kcal*mol-1, indicating that steric destabilizing congestion dominates over electronic 
stabilizing effects. 
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6.2 Redox Reaction Mechanism 
 
6.2.1 The dichotomy of anti-oxidant and pro-oxidant nature of Vitamin E 
 
It is generally accepted that reduction of morbidity and mortality from cardiovascular 
disease is associated with an increased intake of antioxidant Vitamin E and Vitamin C.   
This apparent cause-causality relationship has been explained on the basis of oxidative 
modification of low density lipoprotein (LDL).  The corollary of this assumption is that 
the inhibition of lipid peroxidation in LDL, by Vitamin E, leads to the reduction of 
myocardial infarction and stroke.  Numerous papers testify along this line26, 27, 28. 
 
However, not only does Vitamin E behave as a non-anti-oxidant29, but pro-oxidant30 
effects of Vitamin E have also been demonstrated.   The fact that Vitamin E can act as 
both anti-oxidant and pro-oxidant has led to the point that Vitamin E is know as a 
“Janus molecule”31. 
 
The free radical oxidation products of α-tocopherol have been analyzed by Liebler  
et al32 in 1996, showing other more extensively oxidized products than the quinoidal 
structure.  The ionic mechanism was suggested by Roseman et al;33 in 1999 which has 
led to the quinoidal structure.  These mechanisms were also reviewed recently by 
Brigelius-Floke and Traber34. 
 
Under strong oxidative conditions Vitamin E may undergo progressively more 
extensive oxidation that could lead to irreversible metabolization of the tocopherol 
molecule.  Such a destructive oxidation32, leading to a variety of epoxides, which may 
metabolize even further is shown in Figure 20. Note that the steps in the left hand 
column in Figure 20 are non-destructive as it corresponds to the formation of quinone-
hydroquinone analogues of Vitamin E.  Nevertheless, there exists an ionic oxidative 
mechanism of α-tocopherol leading to a quinoidal or even to a hydroquinone structure33 
shown in Figure 21.   However, some side reactions may occur with the left hand 
column of Figure 21 showing the non-destructive process. 
  31
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: A schematic mechanistic representation of non-destructive (left column) 
and destructive (right column) free radical oxidation of α-tocopherol by HOO·. 
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Figure 21 - A schematic mechanistic representation of non-destructive (left side) and 
destructive (right side) ionic oxidation of α-tocopherol. 
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The free radical as well as an ionic mechanism studied in the present dissertation is 
shown in Figure 22. 
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Figure 22 – Radical and ionic mechanism of α-tocopherol oxidation. 
 
At this time several questions may be raised and some putative answers may be 
provided, in relation to the dichotomy of the anti-oxidant as well as pro-oxidant nature 
of Vitamin E. 
 
Of course one may argue that the anti-oxidant and pro-oxidant nature of Vitamin E 
depends on the redox potential.  In turn, the redox potential varies accord to the Nernst 
equation (14). 
 
E = E0 –  RT / ν ln {[Red]/[Ox]}   (14) 
 
where ν is the number of electrons transferred and the expression [Red]/[Ox] measures 
the ratio of reduced to oxidized forms. 
 
Nevertheless, it seems plausible to seek explanation at the molecular level concerning 
the “traffic” which is passing through the overall reduction presented in Figure 22.  
Sufficient computed results are presented to provide theoretical backing to the merit of 
the questions to be asked along with some suggested putative mechanistic answers. 
 
6.2.2 Molecular geometries 
 
In the ionic mechanism, only compounds labelled 1 and 5, have unsaturated benzenoid 
rings.  The intermediates labelled as 2 and 3 and the product molecule labelled as 4, 
have quinoidal bonding.  However, the quinoidal structure for 4 can clearly be seen in 
Figure 5 and compared to the original Vitamin E model 1.  In the free radical 
mechanisms reactant is labelled as I, intermediates as II and II*, while the products are 
specified as III and IV.  Clearly 1=I, 3=III and 4=IV. Reduced and oxidized structures 
are shown in Figure 23. 
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Figure 23 - Structures of α-tocopherol (top) and α-tocopherolquinone, geometry 
optimized at the B3LYP/6-31G(d)  level of theory, , corresponding to reduced [Red] 
and oxidized [Ox] forms, respectively, in equation (2), optimized at the B3LYP/6-
31G(d) level of theory. All aromatic CC bond lengths in the top structure are in the 
vicinity of 1.40Å. The single and double bond lengths in the ring of the bottom 
structures are in the vicinity of 1.49Å and 1.35Å respectively 
 
 
6.2.3 Free radical oxidative ring opening mechanism for α-tocopherol 
 
Figure 24 shows the energy profile for the free radical mechanism on the basis of the 
data presented in Tables 16 and 17.  The energies of water and oxonium ions necessary 
for the mechanism are shown in Table 9 in the Method section.  The thermodynamic 
reaction profile showing only energy minima, allows a down-hill process in the 
thermodynamic sense.  Consequently, the radical scavenging ability of α-tocopherol is 
well established on energetic grounds.  
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Table 16 - Total energy values of α-tocopherol model and its oxidized forms computed 
at the B3YP/6-31G(d) level of theory 
 
 
 
 
 
 
 
 
 
 
 
Table 17- Total and relative energies for the free radical mechanism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 24 - Reaction profile of non-destructive free radical oxidation of a-tocopherol 
model by HOO·. 
 
reactant, intermediates, product
reactant I -735.31212 1 -735.31212
closed ring intermediate II -734.69317 2 -734.45881
closed ring intermediate II* -885.63012 -
open ring intermediate III -810.84221 3 -810.84221
product IV -810.51082 4 -810.51082
E (Hartree)
Free Radical Route Ionic Route
Route State E(Hartree) ∆E (Kcal·mol-1) ∆∆E (Kcal·mol-1)
Neutral I + 2HOO· + H3O+ + H2O -1190.205294 0.000 0.000
II + HOO· + HOOH + H3O+ + H2O -1190.219272 -8.771 -8.771
II*+ HOOH + H3O+ + H2O -1190.257066 -32.487 -23.716
III + 2HOOH + H2O -1190.315332 -69.050 -36.563
IV + 2HOOH + H3O+ -1190.260897 -34.892 34.159
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The reaction is balanced from reactant (I) to the first ionic product (III) as shown in 
equation (3). 
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I.
+ 2HOO·+H3O
(+) + H2O + 2HOOH + H2O
 
The overall amount of energy released is -32.49 Kcal·mol-1. 
 
While the first step (hydrogen abstraction), may occur by either HO· or HOO· attack. 
the energetics are expected to be considerably more exothermic, by about -32.4 
Kcal·mol-1, with the HO· radical than with the HOO· radical. 
 
 
 
 
 
 
 
 
 
 
 
This would only underline the validity of the conclusion reached when the HOO· 
radical is used. 
 
6.2.4 Ionic Oxidative Ring Opening Mechanism for α-tocopherol 
 
The relative energies necessary to construct a thermodynamic reaction profile for the 
ionic reactions are summarized in Table 16 and 18.  The thermodynamic reaction 
profile (only energy minima, without the appropriate transition states) is shown in 
Figure 25 for α-tocopherol.   The energies of water and oxonium ions necessary for the 
mechanism are shown in Table 9. 
 
Table 18- Total and relative energies for the ionic mechanism 
Hydride 
Abstraction 
Initiator State E(Hartree) ∆E (Kcal·mol-1) ∆∆E (Kcal·mol-1)
1+Li++2H2O -895.414570 0.000 0.000
2+LiH+2H2O -895.358638 35.098 35.098
3+LiH+H2O -895.333085 51.133 16.035
4+LiH+H3O+ -895.278650 85.291 34.159
Li+
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Figure 25 - Reaction profile for ionic oxidation mechanism using Li(+), a hydride 
abstractor modeling NAD(+) 
 
It should be emphasized that the first step involves a hydride acceptor; in biological 
systems it is NAD(+).  However no full computations have been accomplished at the 
DFT level for the NAD(+)/NADH system due to its large size.  Protonated pyridine 
gives hydride affinity close to that of Li(+) therefore this model appears to be fairly 
realistic for NAD(+), at least on energetic grounds. 
 
The reaction was balanced from the reactant (1) to the first ionic product (3) as shown 
in (17), using Li(+) instead of NAD(+). 
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The overall amount of energy change is +85.35 Kcal·mol-1. 
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6.2.5 Ionic Reductive Ring Closing Mechanism in α-Tocopherol 
 
It is clear from Figure 25 that the steps are all endothermic.  This indicates that the 
ionic mechanism is unlikely to occur.  However, the reverse process, namely the 
reduction back from the oxidized α-tocopherol (i.e.  α-tocopherolquinone) to the 
original α-tocopherol, would be expected to be an exothermic process.  Thus, it seems 
that the oxidation proceeds by a free radical mechanism while the reductive conversion, 
back to α-tocopherol, would be expected to proceed via the ionic mechanism.  This 
combined mechanism is shown in Figure 26. 
 
It is believed that the coupled nature of the radical and ionic redox process is shown in 
Figure 26 for the first time. The energy profile for the combined mechanism is 
illustrated in Figure 27. 
 
Since α-tocopherol has been used but not consumed in the coupled reaction, 
α-tocopherol may be regarded as a catalyst for the following overall processes.  
   
2HOO· + H3O(+) + NADH             2HOOH + H2O + NAD(+) ∆E = -120.18 Kcal·mol-1 
 
The essential point is, however, that α-tocopherol can convert the peroxyradical only to 
hydrogen peroxide [H2O2] but not further.  From that point outward, it is the duty of the 
enzyme glutathione peroxidase GPx(Se) or catalase(Fe) to carry the process further 
through the full reduction, to H2O. 
(18) 
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Figure 26 - The connection of a combined non-destructive free-radical and reversible 
ionic mechanism of oxidation of α-tocopherol quionone.  Note the reversible nature of 
the ionic process. 
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Figure 27 - Full cycle of reaction mechanism involving free radical open shell 
oxidation and closed shell recovery of α-tocopherol.  The energy difference between 
initial and final states is related to the process: 2HOO· + Li-H ? HOOH + HOOLi 
 
A schematic illustration of the overall process involving the various enzymes and non 
enzymatic anti-oxidants is shown in Figure 28. 
 
 
 
 
 
 
 
 
 
Figure 28 – The role of various enzymes and antioxidants in the reduction of 
concentration of Reactive Oxygen Species (ROS) 
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The catalytic nature of Vitamin E is illustrated in Figure 29.  Clearly, if Vitamin E was 
destroyed at the end of the first step it could not produce more peroxide.  Thus, under 
such condition its pro-oxidant nature perhaps would not have been ever observed. 
However, Vitamin E is recycled, biologically, as Figure 29 indicates and a single 
α-tocopherol molecule may convert numerous HOO· radical to H2O2 which is 
accumulated if not removed at the same rate enzymatically with the participation of 
catalase(Fe) or glutathione peroxidase, GPx(Se).  This accumulation of peroxide, which 
may be referred to as a “peroxide traffic jam”, may well be the reason of the pro-
oxidant effect of Vitamin E. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 - Overall representation of the catalytic effect of α-tocopherol 
α-Tocopherol α-Tocopherolquinone (protonated)
NADHH2O + NAD
(+)
2 H-O-O-H2 H-O-O· + H3O
(+)
(+)
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6.2.6 Mechanistic comparison of O, S and Se congeners 
 
In closing it may be appropriate to return to the question whether the sulphur or 
selenium congeners of α-tocopherol might exhibit better Vitamin E-like activity. The 
results obtained for the radicaloid oxidative ring opening as well as for the ionic 
reductive ring closing is shown in Figure 30 which is based on the data presented in 
Tables 19-23. It clearly shows that the overall energetics with respect to 
thermodynamics are the same for O, S and Se congeners of α-tocopherol, since they are 
only catalysts which are being used but not consumed in the process. The central 
intermediate in the process (structure III-3 in Figure 30) shows some difference in 
thermodynamic stabilities. However, for full assessment, the transition states must be 
more thoroughly investigated. 
 
Table 19 - Total energy values of α-tocopherol and its congeners and its oxidized 
forms computed at the B3YP/6-31G(d) level of theory 
reactant, intermediates, 
product O S Se
reactant 1 -735.31212 -1058.27672 -3059.47561
closed ring intermediate 2 -734.45881 -1057.41808 -3058.61790
open ring intermediate 3 -810.84221 -1133.79773 -3134.99031
product 4 -810.51082 -1133.46666 -3134.65787
E (Hartree)
 
 
Table 20 - Total and relative energies for the ionic mechanism of α-tocopherol andits 
congeners, computed at the B3LYP/6-31G(d) level of theory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Congener State E(Hartree) ∆E (Kcal·mol-1) ∆∆E (Kcal·mol-1)
1+Li++2H2O -895.414570 0.000 0.000
2+LiH+2H2O -895.358638 35.098 35.098
3+LiH+H2O -895.333085 51.133 16.035
4+LiH+H3O+ -895.278650 85.291 34.159
1+Li++2H2O -1218.379172 0.000 0.000
2+LiH+2H2O -1218.317904 38.447 38.447
3+LiH+H2O -1218.288605 56.832 18.385
4+LiH+H3O+ -1218.234492 90.788 33.956
1+Li++2H2O -3219.578057 0.000 0.000
2+LiH+2H2O -3219.517725 37.859 37.859
3+LiH+H2O -3219.481190 60.785 22.926
4+LiH+H3O+ -3219.425701 95.605 34.820
O
S
Se
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Table 21 – Total energies for free radical mechanism of α-tocopherol and its 
congeners, computed at the B3LYP/6-31G(d) level of theory 
reactant, intermediates, 
product O S Se
reactant I -735.31212 -1058.27672 -3059.47561
closed ring intermediate II -734.69317 -1057.65619 -3058.85517
closed ring intermediate II* -885.63012 -1208.59280 -3209.79780
open ring intermediate III -810.84221 -1133.79773 -3134.99031
product IV -810.51082 -1133.46666 -3134.65787
E (hartree)
 
 
 
Table 22 - Total and relative energies for the free radical mechanism of α-tocopherol 
and its congeners, , computed at the B3LYP/6-31G(d) level of theory 
 
Congener State E(Hartree) ∆E (Kcal•mol-1) ∆∆E (Kcal•mol-1)
I + 2HOO· + H3O+ + H2O -1190.205294 0.000 0.000
II + HOO· + HOOH + H3O+ + H2O -1190.219272 -8.771 -8.771
II*+ HOOH + H3O+ + H2O -1190.257066 -32.487 -23.716
III + 2HOOH + H2O -1190.315332 -69.050 -36.563
IV + 2HOOH + H3O+ -1190.260897 -34.892 34.159
I + 2HOO· + H3O+ + H2O -1513.169896 0.000 0.000
II + HOO· + HOOH + H3O+ + H2O -1513.182291 -7.778 -7.778
II*+ HOOH + H3O+ + H2O -1513.219751 -31.284 -23.506
III + 2HOOH + H2O -1513.270852 -63.351 -32.067
IV + 2HOOH + H3O+ -1513.21674 -29.395 33.956
I + 2HOO· + H3O+ + H2O -3514.368781 0.000 0.000
II + HOO· + HOOH + H3O+ + H2O -3514.381273 -7.838 -7.838
II*+ HOOH + H3O+ + H2O -3514.424750 -35.121 -27.282
III + 2HOOH + H2O -3514.463437 -59.398 -24.277
IV + 2HOOH + H3O+ -3514.407949 -24.578 34.820
O
S
Se
 
 
Table 23 – Full mechanistic relative energies for O, S, Se congeners, computed at the 
B3LYP/6-31G(d) level of theory 
 
Model ∆∆E ∆E ∆∆E ∆E ∆∆E ∆E
I 0.000 0.000 0.000 0.000 0.000 0.000
II -8.771 -8.771 -7.778 -7.778 -7.838 -7.838
II* -23.716 -32.487 -23.506 -31.284 -27.282 -35.120
III -36.563 -69.050 -32.067 -63.351 -24.277 -59.397
2 -16.035 -85.085 -18.385 -81.736 -22.926 -82.323
1 -35.098 -120.183 -38.447 -120.183 -37.859 -120.182
O S Se
E(kcal·mol-1)
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Figure 31 – Ionic reaction profile for X=O, S, and Se oxidative ring opening and  reductive ring closing mechanism using LiH, a 
hydride donor modeling NADH, completed at the B3LYP/6-31G(d) level of theory.
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6.3. Furthur study of Vitamin E Models 
 
6.3.1. Full conformational space of tocopherol models 
 
Furthur investigation leads to the study of the full conformational space of the 
tocopherol model. 
 
X
CH3
R2
R3
HO
R1
H3C
Model A
Model B
Model C
Model D
Model E
 
 
 
Figure 32 – Models of tocopherols 
 
In this computational study, the complete Vitamin E called Model F with full methyl 
substitution (Table 6) is investigated. The full model of α-tocopherol was considered 
for oxygen (II), sulphur (III), and selenium (IV) heteroatoms in the ring. These 
structures, with a fully extended chain with each chain dihedral in the anti position are 
shown. Futhurmore, the chain is investigated with all chain dihedrals set to either 
gauche+ or gauche- conformations. 
 
6.3.2 Preliminary Results 
 
Comparison of the sequence of stabilities shows a non-monotonic change which 
concurs with the results from Model E. The R-C-Me bond angles at the ring 
stereocenter varied the following way:  112.2°(O),  111.6°(S),  112.2°(Se). 
 
X R 2
R 3 
O H 
R 1 
DA(1)
DB(1) DD(1)DC(1) DB(2) DD(2)DC(2)DA(2) DB(3) D D(3) D C(3) DA(3)
Model F 
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Table 24 – Presently optimized dihedral angles of the α-tocopherol sidechain and its 
congeners. (Definition of dihedral angles are shown in Figure 34) 
 
X Level of Theory DA1 DB1 DC1 DD1 DA2 DB2 DC2 DD2 DA3 DB3 DC3 DD3 Total E (Har)
O B3LYP/6-31G(d) 176.520 185.552 184.653 171.764 189.305 175.397 184.248 170.883 188.584 175.106 183.208 171.703 -1285.6982304
S B3LYP/6-31G(d) 175.525 179.987 184.029 169.900 187.985 174.808 183.402 170.396 188.464 175.627 183.661 172.020 -1608.6628400
Se B3LYP/6-31G(d) 174.469 181.136 183.823 170.226 188.012 174.758 183.640 170.871 188.329 175.019 183.256 171.883 -3609.8618088  
 
These dihedrals have been separated into three segments corresponding to the chain 
steric centres. It is important to note the non-monotonic nature of the dihedrals 
especially nearest and furthest away from the ring structure. 
 
Table 25 – Presently optimized ring dihedral angles for O, S, Se 
compounds. 
  
 
 
 
 
 
Furthur computations were made with the sidechain of the O, S, Se congeners in the 
gauche- and gauche+ conformations. Figure 33, 34 show optimized minimum energy 
structures in the fully extended and gauche- conformations. Furthur information, 
including a comparison of the relative energies of these conformers can be found in the 
appendices. 
 
Figure 33 – B3LYP/6-31G(d) optimized minimum energy structure for fully extended 
tail of Selenium congener. 
 
 
 
 
 
 
Figure 34 - B3LYP/6-31G(d) 
optimized minimum energy structure 
for gauche- trend of α-tocopherol. 
4
5
6
1
2
3
D2 D3
D5D6
D1 D4
X Level of Theory D1 D2 D3 D4 D5 D6
O B3LYP/6-31G(d) 0.702 -18.976 47.058 -58.683 42.520 -13.673
S B3LYP/6-31G(d) -0.278 -14.213 43.633 -65.652 52.021 -15.059
Se B3LYP/6-31G(d) -1.936 -10.399 40.386 -66.641 56.581 -16.402
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 7. CONCLUSIONS 
 
7.1 Model A and Model B 
 
It is in human nature to wonder if “Mother Nature” did the best possible structural 
arrangement or whether we can improve upon it.  The question has been asked12, 13 in 
general about antioxidants and in particular about Vitamin E35, 36. 
 
From the present study, one can see that the influence of X = S (III) and X = Se (IV) 
are analogous to one another other but that they are very much different from the X = O 
congener (II).  On the basis of this result, one may expect the Sulphur and the Selenium 
containing compounds to be either much weaker or much stronger antioxidants than the 
Oxygen containing one.  Further research is needed in this area, in order to quantify the 
anti-oxidant characteristics of all topologically probable stable conformers, for each of 
these molecular systems. 
 
7.2 Model C and Model D 
 
The present work shows that O and Se stabilize the fused ring system of Tocopherols 
more or less to the same extent, while S destabilizes it slightly. 
 
The stabilization is of the following order: 
 
   O     ≈     Se   >>      S 
-4.82  -4.73  +1.19 (Kcal•mol-1) 
 
It remains to be seen if the energies of the red-ox reaction mechanism follow the same 
sequence. 
 
7.3 Model E 
 
Both Me and heteroatom substitution change the molecular structure of Vitamin E, in 
terms of bond lengths, bond angles and dihedral angles.  The effect of Me substitution 
was observed predominantly in the case of adjacent bond lengths, while heteroatom 
substitution influenced bond angles and dihedral angles. 
 
With the exception of the model of β-tocopherol, where the 2 introduced Me groups 
(para-orientation) nearly cancel their electronic contribution and provide little steric 
congestion, a general trend was observed with increasing substitution in the following 
sequence δ ? γ ? α.  The structural contribution is measured by the relative stabilities 
in Kcal·mol-1 units, with δ being the most stable and α being the least stable.  This 
trend correlated with the logarithmic relative activity of the Vitamin E homologues δ, γ 
and α, respectively. 
 
This clearly indicates that there is a structural basis for the differing biological activity 
of the naturally occurring tocopherol homologues. 
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7.4 Mechanism 
 
If Vitamin E reacts with HO· radical then the radical is converted to H2O which 
represents no further biological detriment, as it is the last structure in the overall 
reductive process starting with O2.  However, when Vitamin E reacts with HOO· then 
the peroxyradical is converted to hydrogen peroxide (H2O2) which could cause 
oxidative damage. 
 
The present investigation has shown that a substantial fraction of the oxidized Vitamin 
E may be reduced back to active Vitamin E which could, in turn, produce more 
hydrogen peroxide.  The responsibility of removal of the hydrogen peroxide from the 
system is bestowed upon two enzymes: the iron containing catalase (Fe) and the 
selenium containing glutathione peroxidase, GPx(Se).  If there is a noticeable 
concentration reduction of these enzymes, then the peroxides accumulate, leading to a 
“peroxide traffic-jam”.  This can happen for example if the Se supply is low, as 
discussed at the beginning of this dissertation.  Of course, the accumulated H2O2, 
produced by Vitamin E, can make a great deal of damage and thus consequently 
Vitamin E may well be misjudged to be a pro-oxidant, while the phenomenon may be 
due to the low level of selenium (Se). 
 
 
 
 
 
 
 
 
 
 
 
It now appears that future clinical studies, designed to investigate the efficacy (the anti-
oxidant effect) and the toxicity of the accumulated peroxide (via the pro-oxidant effect) 
of Vitamin E should include the monitoring of other participating components of the 
detoxification process of ROS.  Such studies should include the monitoring of the level 
of catalase (Fe or Mn) as well as glutathione peroxidase (Se).  Nutritionists37 and 
Biochemists38 have already questioned whether the imbalance of these enzymes could 
be a significant contributor to the damages originated from oxidative stress. 
 
 
O 2 O 2 H O - O H O H 2 OH 2 O 2
V it . C /E V it . C /E
S O D  (C u /Z n ) G P x  (S e )
C a ta la se  (F e )
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Tetralin, chroman as well as its’ S and Se containing congeners were subjected to ab initio (RHF/3-21G and RHF/6-31G(d))
and DFT (B3LYP/6-31G(d)) computation. Molecular geometries and the activation energies for ring inversions were
determined with full geometry optimizations. q 2002 Elsevier Science B.V. All rights reserved.
Keywords: Tocopherol models; Tocotrienol models; Vitamin E as an antioxidant; Molecular structure; Ring inversion; HF and DFT
computations
1. Preamble
Vitamin E, a term [1] introduced in 1922, does not
represent a single compound but in fact includes two
families of compounds; mainly tocopherols and toco-
trienols. Both families consist of a chroman (benzpyr-
ane) ring structure and a sidechain, the latter having the
characteristic isoprenoid skeleton, typical of terpenes.
Members of the tocopherol family have saturated
sidechains but the same sidechain in the tocotrienol
family has three non-conjugated double bonds. Such
carbon–carbon double bonds are separated by –CH2–
CH2– units. For both families, the carbon atom that
carries the sidechain is a stereocenter of R configuration,
however, the sidechain of the tocopherols has two
additional stereocenters, at the branching points both of
which are of R configuration. The structural variations
of the two families are shown in Fig. 1.
Each of these families have four homologous
members (Table 1), labeled as a, b, g, and d. They
differ from each other in the extent of the methyl
substitution in the aromatic ring. Overall, these two
(2) families of compounds (tocopherol and tocotrie-
nol) and each may come in four (4) homologous
forms. The natural abundance of these 2 £ 4 ¼ 8
components of the vitamin E family varies from plant
to plant [2] as summarized in Table 2.
0166-1280/02/$ - see front matter q 2002 Elsevier Science B.V. All rights reserved.
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Of these eight species, it is a-tocopherol which is
most frequently used partly because it is commer-
cially available in synthetic form, which does not
come as a pure enantiomeric mixture. The effective-
ness of the synthetic racemic mixture has traditionally
been questioned, lacking an explanation at the
molecular level. The primary function of vitamin E
is, however, as an antioxidant, undergoing an
oxidation reaction at the molecular level. Presently,
we have more precise data to support this traditional
assumption [3], as shown in Table 3.
Recently it has been suggested [4] that the
selenium congener of a-tocopherol (Fig. 2) may be
a very effective antioxidant. For this reason, we
wish to study the structure of the chroman ring
together with its S and Se congeners. We also wish
to compare chroman with its hydrocarbon analog
(tetralin).
All of these compounds (I, II, III, and IV) are
depicted in Section 3 below.
2. Introduction
2.1. Oxidative stress and vitamin E
One of the major current theories of aging as well
as of the origin of numerous degenerative diseases is
Fig. 1. Structures of tocopherols and tocotrienols. Substituents R1, R2 and R3 are specified in Table 1.
Table 1
Extent of methyl substitutions of the tocopherol and tocotrienol
families
R1 R2 R3
a Me Me Me
b Me H Me
g H Me Me
d H H Me
Table 2
Typical vitamin E content of selected foods (based on a-tocopherol
activity)
Vitamin E
mg/100 g
food portion
IU/100 g
food portiona
Wheat germ oil 119 178
Sunflower oil 49 73
Peanut oil 19 28
Soybean oil 8.1 12
Butter 2.2 3.2
Sunflower seeds, raw 50 74
Almonds 27 41
Peanuts, dry roasted 7.4 11
Asparagus, fresh 1.8 2.7
Spinach, fresh 1.8 2.7
a 1 mg a-tocopherol equivalent to 1.49 IU.
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Table 3
Relative activity of tocopherol and tocotrienol stereoisomers and their acetates
Natural vitamin E derivatives Activity (%) Synthetic vitamin E derivatives Activity (%)
RRR-a-tocopherol 100 RRR-a-tocopheryl acetate 100
RRR-b-tocopherol 57 RRS-a-tocopheryl acetate 90
RRR-g-tocopherol 37 RSS-a-tocopheryl acetate 73
RRR-d-tocopherol 1.4 SSS-a-tocopheryl acetate 60
R-a-tocotrienol 30 RSR-a-tocopheryl acetate 57
R-b-tocotrienol 5 SRS-a-tocopheryl acetate 37
SRR-a-tocopheryl acetate 31
SSR-a-tocopheryl acetate 21
Fig. 4. Conformation and dihedral angles of cyclohexene as part of the tetralin ring system. The ring may exist in two enantiomeric forms. The
signs in one of the enantiomers are as shown in the figure. In the other enantiomer, the dihedral angles are of opposite sign.
Fig. 2. Seleno-congener of a-tocopherol.
Fig. 3. Ring-flip in dihydropyran.
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associated with a variety of free radical reactions
within the human body [5]. These reactions are
collectively referred to as oxidative stress.
Free radicals are generated as by-products of redox
reactions associated with metabolism [6]. These
include the superoxide anion (O2
2), the hydroperoxyl
radical (HOO), hydrogen peroxide (H2O2) and the
hydroxyl radical (HO). These are collectively referred
to as ‘reactive oxygen species’ (ROS) and are all very
reactive in the body and therefore short-lived.
Normally, there are natural mechanisms defending
against the free radicals within the body [7], which
may be enzymatic or non-enzymatic. However, if for
some reason, these defense mechanisms become
weakened then the free radicals can react with cellular
structures such as DNA as well as proteins, or even
destroy membranes through lipid peroxidation
[8–10]. It is generally believed that through these
processes, aging and other age-related degenerative
diseases such as cardiovascular disorders and cancer
are induced [1]. Recently, oxidation of a methionine
residue has been implicated [11] in Alzheimer’s
disease as a result of oxidative stress.
Vitamin E is a potent antioxidant that helps prevent
cancer by blocking lipid peroxidation, as well as the
oxidation of polyunsaturated fats into free radicals.
Lipid peroxidation is potentially important in all
cancers but is especially significant as a cause of
breast and colon cancers.
Vitamin E also serves a crucial role in the
function of the immune system. A low level of this
vitamin leads to impaired antibody production,
inability to manufacture T and B lymphocytes
and reduced resistance to cancer and infection.
Vitamin E works synergistically with vitamin C
and the mineral selenium, with which it has a special
affinity. Selenium and vitamin E combined, constitu-
tes a double defense against cancer. As it is not
possible to obtain optimally protective quantities of E
from diet alone, supplements of 40–1600 inter-
national units (IU) are recommended daily.1
2.2. Structural background
One of the structural problems of vitamin E is
associated with the saturated ring fused to the benzene
ring. This ring cannot be considered to be cyclohex-
ane or its heterocyclic analogues in a boat confor-
mation because it has, at least formally, one carbon–
carbon double bond. The so-called ‘half-chair’
conformation had been considered to be the most
likely structure, before experimental observation
provided strong support for that assumption.
The ring is expected to exist in two interconvertible
enantiomeric forms, with the transition state for such a
ring-flip expected to show some symmetry. It is
tempting to consider the planar structure to be a good
Fig. 5. Tetraline, chroman and its S and Se congeners.
Fig. 6. Definition of the spatial orientation of atomic nuclei used for
molecule including the numeric definition of relevant dihedral
angles.1 1 mg a-tocopherol ¼ 1.49 IU.
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candidate for the transition state but such a confor-
mation could be a higher order critical point. It is more
likely that the transition state is a boat conformation
(Fig. 3).
Of the four CH2 groups found in tetralin, the
two allylic CH2 exhibit quasiaxial or pseudoaxial
(a0) and quasiequatorial or pseudoequatorial (e0)
orientation, while the orientation of the central
Table 4
Optimized bond lengths for the stable conformers ðl ¼ 0Þ of compounds I, II, III, and IV obtained at three levels of theory
X 1 2 3 4 5 6 7 8 9 10
HF/3-21G CH2 1.3900 1.3912 1.3790 1.3855 1.3790 1.3912 1.5241 1.5241 1.5374 1.5374
O 1.3855 1.3880 1.3800 1.3872 1.3774 1.3860 1.3772 1.5197 1.4451 1.5396
S 1.3843 1.3918 1.3787 1.3848 1.3782 1.3865 1.8356 1.5208 1.8872 1.5374
Se 1.3862 1.3868 1.3821 1.3828 1.3814 1.3832 1.9231 1.5125 1.9950 1.5459
HF/6-31G(d) CH2 1.3927 1.3940 1.3799 1.3879 1.3799 1.3940 1.5191 1.5191 1.5283 1.5283
O 1.3895 1.3923 1.3802 1.3895 1.3786 1.3906 1.3550 1.5155 1.4079 1.5283
S 1.3924 1.3942 1.3795 1.3872 1.3786 1.3943 1.7823 1.5186 1.8133 1.5265
Se 1.3926 1.3890 1.3843 1.3843 1.3835 1.3882 1.9073 1.5106 1.9692 1.5346
B3LYP/6-31G(d) CH2 1.4066 1.4026 1.3920 1.3970 1.3920 1.4027 1.5203 1.5203 1.5339 1.5338
O 1.4054 1.4005 1.3930 1.3984 1.3908 1.4004 1.3717 1.5163 1.4306 1.5338
S 1.4072 1.4024 1.3920 1.3965 1.3907 1.4044 1.7884 1.5182 1.8364 1.5321
Se 1.4053 1.3996 1.3945 1.3956 1.3935 1.3998 1.9150 1.5101 1.9970 1.5421
11 12 13 14 15 16 17 18 19
HF/3-21G CH2 1.5368 1.0847 1.0871 1.0844 1.0855 1.0855 1.0844 1.0871 1.0847
O 1.5286 1.0836 1.0865 1.0833 1.0833 1.0837 1.0781 – –
S 1.5268 1.0836 1.0870 1.0855 1.0830 1.0787 1.0791 – –
Se 1.5339 1.0829 1.0865 1.0852 1.0825 1.0796 1.0791 – –
HF/6-31G(d) CH2 1.5268 1.0861 1.0889 1.0861 1.0881 1.0881 1.0861 1.0889 1.0861
O 1.5188 1.0853 1.0881 1.0856 1.0860 1.0878 1.0808 – –
S 1.5234 1.0852 1.0887 1.0866 1.0853 1.0835 1.0828 – –
Se 1.5251 1.0842 1.0886 1.0868 1.0850 1.0806 1.0804 – –
B3LYP/6-31G(d) CH2 1.5327 1.0977 1.1011 1.0968 1.0993 1.0993 1.0968 1.1010 1.0977
O 1.5245 1.0969 1.1002 1.0963 1.0971 1.1009 1.0932 – –
S 1.5272 1.0967 1.1011 1.0977 1.0967 1.0955 1.0942 – –
Se 1.5261 1.0956 1.1009 1.0982 1.0963 1.0924 1.0921 – –
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CH2 –CH2 moiety is expected to be close to
non-cyclic molecules such as ethane or butane
(Fig. 4).
Thus, the further away one moves away from
the double bond, the closer one comes to the ideal
planar situation. Estimated dihedral angles ðDiÞ are
shown in Fig. 4. While we cannot extrapolate in a
blindfolded way to the stereochemistry of tetralin
from the conformations of cyclohexene, some
analogy is nevertheless expected.
3. Method
Molecular orbital computations were carried out,
using the GAUSSIAN98 program package [13], on the
following four compounds: tetralin (I), chromane (II),
thiochroman (III), and selenochroman (IV) as shown
in Fig. 5.
Two methods and two split-valence basis sets were
used, mainly the RHF/3-21G, RHF/6-31G(d) and the
B3LYP/6-31G(d) levels of theory. Convergence
criteria of 3.0 £ 1024, 4.5 £ 1024, 1.2 £ 1023,
1.8 £ 1023 are used for the gradients of the RMS
(root mean square) force, maximum force, RMS
displacement and maximum displacement vectors,
respectively.
Since it is generally believed that the tail end of
tocopherols are only needed to enhance fat solubility
[12] it is appropriate to concentrate on the fused ring
systems (II, III, and IV). Compounds III and IV are
congeners of II. All of these compounds lack the
symmetry, which is present in I.
The definition of the spatial orientation of the
Fig. 7. Variation of selected bond lengths as a function of atomic
radii.
Fig. 8. Variation of selected bond-angles as a function of atomic
radii.
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Table 5
Optimized bond-angles for the stable conformers ðl ¼ 0Þ of compounds I, II,III, and IV obtained at three levels of theory
X 1 2 3 4 5 6 7 8 9 10
HF/3-21G CH2 121.746 121.748 112.682 109.374 109.372 112.683 107.341 107.856 107.856 107.344
O 122.827 120.267 110.538 108.812 110.519 118.565 106.667 108.627 109.3 –
S 124.136 123.089 113.721 110.859 111.423 102.205 107.263 108.13 109.581 –
Se 121.362 120.21 110.281 112.012 113.889 99.633 107.824 107.89 109.018 –
HF/6-31G(d) CH2 121.624 121.623 113.133 110.229 110.222 113.133 106.163 106.876 106.879 106.159
O 122.703 120.505 110.574 109.16 111.16 117.51 106.54 107.649 108.289 –
S 124.228 123.424 114.721 111.359 112.054 102.191 106.143 107.342 107.798 –
Se 121.434 120.45 111.626 112.671 113.646 101.09 106.964 107.06 108.663 –
B3LYP/6-31G(d) CH2 121.478 121.474 113.377 110.288 110.291 113.385 105.707 106.735 106.735 105.716
O 123.14 120.367 110.734 109.179 111.805 116.747 106.132 107.498 108.246 –
S 124.43 123.008 114.512 111.518 112.445 102.512 105.813 107.232 107.869 –
Se 121.524 120.5 111.714 112.709 113.499 100.694 106.843 107.001 108.92 –
Table 6
Optimized dihedral angles for the stable conformers ðl ¼ 0Þ of compounds I, II, III, and IV obtained at three levels of theory
X 1 2 3 4 5 6
HF/3-21G CH2 2.846 218.423 48.888 265.027 48.887 218.423
O 0.412 220.849 49.302 260.512 41.697 211.236
S 1.199 231.5 65.183 264.182 31.667 21.341
Se 24.002 251.068 76.461 242.076 24.838 29.465
HF/6-31G(d) CH2 2.78 217.803 47.322 262.972 47.335 217.821
O 0.557 216.368 44.563 261.353 47.083 216.406
S 2.811 224.168 56.637 265.581 39.916 210.067
Se 23.821 247.803 74.718 244.392 20.755 25.879
B3LYP/6-31G(d) CH2 3.264 218.123 47.228 262.512 47.172 218.068
O 0.228 217.573 45.834 261.223 44.939 214.149
S 2.654 227.094 59.079 264.009 36.08 26.74
Se 23.888 247.917 75.163 244.71 20.484 25.773
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constituent atomic nuclei, shown in Fig. 6, was used in
numerically generating the input files. No visualiza-
tion tool was used for this purpose. It should be noted
that H21 and H22 are present only in tetralin (I) but
they are absent in chroman (II) and its higher
congeners (III and IV).
For the sake of convenience, the variations of
geometrical and energetic parameters from O to S to
Se were fitted to quadratic functions, even though no
quadratic relationships are assumed to be operative.
For such graphical presentation the optimized par-
ameters were plotted against the covalent atomic
radii: O ¼ 0:745 A; S ¼ 1:040 A; and Se ¼ 1:163 A
[14,15].
4. Results and discussion
Higher levels of theory are more reliable, therefore
the majority of the discussion will be focused on the
results obtained at the DFT level.
4.1. Molecular geometry of stable structures
The optimized bond lengths show no deviations
from expected structural behavior. The greatest
Fig. 11. Variation of energy of activation for ring inversion of
chroman as well as S and Se congeners.
Fig. 9. Variation of selected dihedral angles as a function of atomic
radii.
Fig. 10. RHF/6-31G(d) optimized minimum energy and transition
structures for chroman. The sulphur and selenium congeners have
analogous geometries.
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change is expected in the C–X–C region, specifically
bond lengths labeled as 7 and 9, as shown in Table 4.
The C–X involving the aromatic carbon (7) is slightly
shorter than the other one involving the aliphatic
carbon (9). These optimized bond lengths correlate
linearly with the covalent radii of O, S, and Se, as
shown in Fig. 7.
The C–X–C and the X–C–C bond-angles,
Table 7
Optimized bond lengths for the ring inversion transition structure ðl ¼ 1Þ of compounds I, II, III, and IV obtained at three levels of theory
X 1 2 3 4 5 6 7 8 9 10
HF/3-21G CH2 1.3909 1.3872 1.3829 1.3832 1.3830 1.3861 1.5149 1.5213 1.5406 1.5656
O 1.3836 1.3842 1.3845 1.3848 1.3826 1.3796 1.3839 1.5153 1.4542 1.5629
S 1.3844 1.3924 1.3794 1.3848 1.3792 1.3844 1.8296 1.5265 1.8836 1.5624
Se 1.3852 1.3930 1.3784 1.3844 1.3780 1.3861 1.9231 1.5289 1.9724 1.5617
HF/6-31G(d) CH2 1.3909 1.3889 1.3847 1.3846 1.3848 1.3882 1.5113 1.5166 1.5405 1.5533
O 1.3888 1.3855 1.3870 1.3855 1.3860 1.3821 1.3591 1.5096 1.4139 1.5454
S 1.3930 1.3929 1.3818 1.3862 1.3811 1.3910 1.7786 1.5207 1.8135 1.5510
Se 1.3918 1.3942 1.3811 1.3863 1.3805 1.3908 1.9063 1.5237 1.9466 1.5521
B3LYP/6-31G(d) CH2 1.4069 1.3996 1.3949 1.3957 1.3949 1.3988 1.5119 1.5169 1.5374 1.5602
O 1.4021 1.3961 1.3972 1.3970 1.3960 1.3942 1.3760 1.5085 1.4388 1.5496
S 1.4069 1.4027 1.3930 1.3965 1.3921 1.4018 1.7864 1.5208 1.8360 1.5568
Se 1.4051 1.4040 1.3926 1.3963 1.3918 1.4006 1.9171 1.5239 1.9726 1.5580
11 12 13 14 15 16 17 18 19
HF/3-21G CH2 1.5420 1.0860 1.0834 1.0840 1.0834 1.0844 1.0839 1.0873 1.0836
O 1.5393 1.0848 1.0825 1.0819 1.0831 1.0775 1.0826 – –
S 1.5263 1.0851 1.0831 1.0818 1.0851 1.0792 1.0788 – –
Se 1.5278 1.0832 1.0854 1.0854 1.0820 1.0796 1.0807 – –
HF/6-31G(d) CH2 1.5344 1.0875 1.0847 1.0857 1.0850 1.0861 1.0864 1.0897 1.0851
O 1.5368 1.0866 1.0842 1.0844 1.0853 1.0802 1.0855 – –
S 1.5242 1.0864 1.0842 1.0837 1.0864 1.0829 1.0831 – –
Se 1.5219 1.0842 1.0865 1.0871 1.0834 1.0812 1.0817 – –
B3LYP/6-31G(d) CH2 1.5393 1.0996 1.0962 1.0968 1.0960 1.0968 1.0976 1.1017 1.0964
O 1.5459 1.0990 1.0953 1.0953 1.0962 1.0924 1.0984 – –
S 1.5271 1.0986 1.0959 1.0950 1.0981 1.0941 1.0952 – –
Se 1.5236 1.0960 1.0987 1.0990 1.0949 1.0929 1.0929 – –
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labeled 6 and 5, respectively, are of greatest
interest. The results are summarized in Table 5.
Values show bond-angle 6 as undergoing the
greatest change as the bond-angle (6) moves from
a value larger than tetrahedral towards 908, typical
of S and Se. The diminishing of the C–C–C
bond-angle is nearly exponential. In contrast to
this, the X–C–C bond-angle (5) is compensating
for such a dramatic closing in 6, through a modest
opening in the X–C–C (5) values. These changes
at the DFT level are evaluated as moving from
111.88 for (X ¼ oxygen) to 113.58 (X ¼ selenium).
The change is illustrated in Fig. 8.
For the torsion of the heterocyclic ring, dihedral
angles behave in an interesting way as summarized in
Table 6. The dihedral angles 1 and 4 behave in non-
routine fashion, much as if the influence of the X nucleus
on these two dihedrals was inconsequential. Dihedral
angles 2 and 6 are similar in magnitude and 3 and 5 are
nearly identical. Yet they show deviation from one
another as X ¼ oxygen is replaced by sulfur and then by
selenium. The variations of these dihedral angles are
shown in Fig. 9.
4.2. Molecular geometries at transition structures
The ring inversion (Fig. 3) was studied in the cases of
compounds I, II, III, and IV. For compound II
(X ¼ oxygen) the initial state, the transition state and
the final states are shown in Fig. 10 as structures
optimized at the RHF/6-31G(d) level of theory. Clearly,
the fused heterocyclic ring exhibits a highly distorted
boat arrangement (Fig. 10) in comparison to the
idealized case given in Fig. 3. The optimized geometri-
cal parameters, specifically bond lengths, bond-angles,
Table 8
Optimized bond-angles lengths for the ring inversion transition structure ðl ¼ 1Þ of compounds I, II, III, and IV obtained at three levels of
theory
X 1 2 3 4 5 6 7 8 9 10
HF/3-21G CH2 118.481 120.394 115.204 113.747 109.880 108.287 106.723 107.160 108.039 107.814
O 119.054 118.148 113.933 112.397 111.421 112.618 107.247 107.733 109.461 –
S 120.569 124.084 118.153 114.424 109.213 106.717 106.677 107.545 109.861 –
Se 121.210 124.870 119.284 114.852 109.795 92.215 106.533 107.393 109.128 –
HF/6-31G(d) CH2 118.349 119.989 115.473 114.251 111.242 109.187 105.616 106.124 106.900 106.696
O 118.525 116.941 112.612 112.228 112.666 112.839 106.495 106.730 108.159 –
S 120.520 123.287 117.979 114.809 111.357 96.620 105.681 106.677 107.989 –
Se 120.409 124.462 119.366 115.423 109.822 93.170 105.539 106.754 108.826 –
B3LYP/6-31G(d) CH2 118.318 119.932 115.608 114.075 111.247 109.269 105.202 106.025 106.843 106.432
O 118.847 116.619 112.609 112.047 113.735 112.492 106.344 106.758 108.125 –
S 120.632 123.246 118.153 114.607 111.553 96.357 105.249 106.592 108.111 –
Se 120.556 124.466 119.483 115.213 109.884 92.727 105.130 106.676 109.050 –
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and dihedral angles are summarized in Tables 7–9,
respectively.
4.3. Energetics of ring inversion
The energies of activations for the four compounds
are tabulated in Table 10 at three levels of theory. The
Ea values for the X ¼ [O,S,Se] containing molecules
(II, III, and IV, respectively) were plotted against the
covalent radii of X. The difference between O and S is
large while the difference between S and Se is small
(Fig. 11).
5. Conclusions
It is in human nature to wonder if ‘Mother
Nature’ did the best possible structural arrange-
ment or whether we can improve upon it. The
question has been asked [13,14] in general, about
antioxidants and in particular about vitamin E
[16,17].
From the present study, one can see that the
influence of X ¼ S (III) and X ¼ Se (IV) are
analogous to one another other but that they are
very much different from the X ¼ O congener (II).
On the basis of this result, one may expect the
sulfur and the selenium containing compounds to
be either much weaker or much stronger antiox-
idants than the oxygen containing one. Further
research is needed in this area, in order to
quantify the antioxidant characteristics of all
topologically probable conformers, for each of
these molecular systems.
Table 9
Optimized dihedral angles lengths for the ring inversion transition structure ðl ¼ 1Þ of compounds I, II, III, and IV obtained at three levels of
theory
X 1 2 3 4 5 6
HF/3-21G CH2 25.450 29.194 23.496 241.810 64.682 241.565
O 26.334 34.135 212.900 232.037 62.593 243.335
S 25.213 26.268 8.548 256.141 65.340 236.158
Se 5.727 225.247 210.899 57.659 263.418 33.606
HF/6-31G(d) CH2 25.373 30.931 27.783 237.100 61.774 240.922
O 24.317 38.477 222.512 223.716 60.899 47.071
S 25.557 27.952 3.567 251.108 63.113 235.800
Se 5.702 226.868 28.217 55.624 263.275 34.382
B3LYP/6-31G(d) CH2 25.942 30.989 27.284 237.662 61.906 240.379
O 24.454 41.093 227.214 219.083 57.513 246.097
S 27.029 28.945 3.624 251.440 62.871 234.495
Se 6.923 227.559 28.676 56.325 262.266 33.300
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Table 10
Optimized total energies for stable conformers ðl ¼ 0Þ and ring inversion transition structure ðl ¼ 1Þ as well as the associated energy of
activation of compounds I, II, III, and IV obtained at three levels of theory
E (hartree)
X Min TS Ea (kcal/mol)
HF/3-21G
CH2 2383.543851545 2383.538891934 3.112205499
O 2419.162508351 2419.154678402 4.913371297
S 2740.280616962 2740.276189519 2.778264757
Se 22733.219289040 22733.212773800 4.088378253
HF/6-31G(d)
CH2 2385.686372822 2385.680849545 3.465911550
O 2421.501191382 2421.493978702 4.526028827
S 2744.156982123 2744.152313980 2.929306414
Se 22744.222591050 22744.218050310 2.849359758
B3LYP/6-31G(d)
CH2 2388.306393922 2388.301776427 2.897524287
O 2424.203406366 2424.196005393 4.644184567
S 2747.177884971 2747.173343996 2.849507222
Se 22748.368331440 22748.363874870 2.796542241
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Abstract. The molecular conformations of shortened molecular models of vitamin E (tocopherol and to-
cotrienol) and their sulfur and selenium congeners were studied computationally at the DFT level of theory
[B3LYP/6-31G(d)]. The sequence of stabilization by the various heteroatoms was found to be the following:
O  Se > S: On the basis of the present structural results it seems that the seleno-congener of vitamin E
is a distinct possibility.
PACS. 31.15.Ar Ab initio calculations
1 Introduction
It is in human nature to wonder if \Mother Nature" always
did the best possible structural arrangement for bioactive
molecules, or whether we can improve upon it. The ques-
tion has been asked in general about antioxidants, and in
particular about vitamin E [1,2].
1.1 Vitamin E structures
Vitamin E, a term introduced in 1922 [3], does not rep-
resent a single compound but includes two families of
compounds: tocopherols and tocotrienols. Both families
consist of a chroman [benzpyrane] ring structure and
a sidechain. The sidechain contains an isoprenoid skele-
ton, typical of terpenes. Members of the tocopherol fam-
ily have saturated sidechains, but the same sidechain in
the tocotrienol family has three non-conjugated double
bonds. For both families, the carbon atom that carries
the sidechain is a stereo centre of the R conguration.
However, the sidechains of tocopherols have two additional
a e-mail: dsetiadi@fixy.org
b e-mail: gchass@fixy.org
c e-mail: pyro@phcol.szote.u-szeged.hu
d e-mail: varro@phcol.szote.u-szeged.hu
e e-mail: papp@phcol.szote.u-szeged.hu
f e-mail: icsizmad@alchemy.chem.utoronto.ca
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CH3
Tocopherol
Tocotrienol
Fig. 1. Structures of tocopherols and tocotrienols. Substients
R1, R2, R3 are hydrogens or methyl groups.
stereo-centres at their branching points, both of which are
of R conguration. The structural variations of the two
families are shown in Figure 1.
Each of these families has four homologous members,
labeled as , , γ, and . They dier from each other in the
extent of methyl substitution in the aromatic ring. Thus,
these are two (2) families of compounds (tocopherol and
tocotrienol) and each may come in four (4) homologous
forms [4].
Of these 2 4 = 8 species, it is -tocopherol which is
most frequently used, partly because of its commercial
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Se
CH3
R2
CH3
HO
R1
H3C H3C H3C
CH3
Fig. 2. Seleno-congener of -tocopherol.
availability in synthetic form. Of course, the synthetic
form is not a pure enantiomer. The eectiveness of the syn-
thetic form has been questioned, without an explanation
at the molecular level even though the primary function of
vitamin E is an antioxidant rather than taking part in an
oxidation reaction. Presently, we have more precise data
to support the earlier assumption [5] that the dierent
stereoisomers exhibit dierent eectiveness of biological
activity.
It has recently been suggested [6] that the selenium
congener of -tocopherol [Fig. 2] may be a very eective
antioxidant. Thus, one may ask if the sulphur (S) and sele-
nium (Se) congeners of vitamin E might be more ecient
antioxidants than vitamin E itself. The answer to such a
question may be decided by studying the redox mechanism
of the three congeners containing O, S and Se.
1.2 Conformational background
One of the structural problems of vitamin E is associated
with the saturated ring fused to the benzene ring. This
ring cannot be considered to be cyclohexane, nor any of
its heterocyclic analogues in the chair conformation, be-
cause it has, at least formally, one carbon-carbon double
bond. The so-called \half-chair" conformation had been
considered to be the most likely structure and was con-
rmed by experiment [7{13].
Of the four CH2 groups found in tetralin, the two
allylic CH2 exhibit quasiaxial or pseudoaxial (a0) and
quasi-equatorial or pseudo-equatorial (e0) orientation. The
orientation of the central CH2{CH2 moiety is expected to
be close to non-cyclic molecules such as ethane or butane.
Thus, the further one moves away from the double bond,
the closer one comes to the ideal planar situation. Esti-
mated dihedral angles (Di) are shown in Figure 3.
The ring is expected to exist in two inter-convertible
enantiomeric forms, with the transition state for such a
ring-flip expected to show some molecular symmetry; in-
terconnecting the two non-super-imposable mirror image
(enantiomer) minima on either side. It is tempting to con-
sider the planar structure to be a good candidate for the
transition state, but such a conformation could be a higher
order critical point. It is more likely that the transition
state is a boat conformation. The ring-inversion has been
studied computationally in the case of tetralin as well as
its oxygen, sulfur and selenium congeners [14].
4
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1
6
D(5-6-1-2) = -15.2
o
D(4-5-6-1) = 44.2
o
D(2-3-4-5) = 44.2
o
D(1-2-3-4) = -15.2
o
D(6-1-2-3) =0
o
D(3-4-5-6) = -60.2
o
Fig. 3. Previously reported conformation and dihedral angles
of cyclohexene.
2 Method
Since it is generally believed that the hydrocarbon tails
of tocopherols are only necessary to enhance fat solubil-
ity [15] or \anity" for hydrophobic environs, it is appro-
priate to concentrate an \activity"-related investigation
(antioxidative character) on the fused ring systems, with-
out the tail end.
Molecular orbital computations were carried out us-
ing the Gaussian 98 program package [16]. All computa-
tions were carried out at the B3LYP/6-31G(d) level of
theory. Convergence criteria of 3:0  10−4, 4:5  10−4,
1:2  10−3 and 1:8  10−3 were used for the gradients
of the RMS (root mean square) Force, Maximum Force,
RMS Displacement and Maximum Displacement vectors,
respectively.
Four families (A, B, C, D) of the four compounds (I, II,
III, IV) were studied as shown in Figure 4. All together,
sixteen compounds were studied. Compound III and IV
are sulfur and selenium congeners of II.
The denition of the spatial orientation of the con-
stituent atomic nuclei shown in Figure 4 was used in nu-
merically generating the input les. No visualization tool
was used for any purpose for this work. It should be noted
that there are two extra hydrogen atoms in the carbon
congeners (i.e. X = CH2) of IA, IB, IC and ID. The po-
sition of these two hydrogen atoms were optimized but
omitted from the tabulated data. Key torsional angles are
dened in Figure 5.
In order to compare the relative stabilities of the
X = O, S and Se congeners, the following three isodesmic
reactions were applied.
(3a)
EIC:stab=[E(IC] + E(C6H10]−[E(IB)+E(C6H8EtMe)]
(3b)
(4a)
EXC:stab =[E(XC + E(IA)]−[E(IC) + E(XA)] (4b)
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Fig. 4. Atomic numbering of the sixteen compounds studied.
(5a)
EXD:stab = [E(XD + E(PhH)]−[E(XC) + E(phOH)]:
(5b)
The overall stabilization energy is the sum of the two in-
dividual stabilization energies
ETotal:stab = EXD:stab + EXC:stab: (6)
Replacing oxygen (O) to sulfur (X = S) or selenium
(X = Se). We may also obtain isodesmic energies as listed
below in equations (7a, 7b)
(7a)
EO!X
Where X=S or Se
= [E(XD) + E(OA)]− [E(OD + E(XA)]:
(7b)
For the sake of convenience, the variations of geometrical
and energetic parameters from O to S to Se were tted to
 
 
 
Fig. 5. Denition of key dihedral angles.
quadratic functions, even though no quadratic relation-
ships are assumed to be operative. For such graphical pre-
sentation the optimized parameters were plotted against
the covalent atomic radii: O = 0:745 A, S = 1:040 A and
Se = 1:163 A [8,9].
3 Results and discussion
Although computations have been carried out at several
levels of theory, only the results obtained at the highest
level [B3LYP/6-31G(d)] are reported in this work.
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Fig. 7. Geometrical variation in cyclohexene as a result of oxygen, sulfur and selenium substitution. Atomic radii in angstrom
on horizontal axis.
3.1 Molecular geometry of stable structures
The labeling of the bond lengths, bond angles and dihe-
dral angles are given in Figure 6. The corresponding op-
timized parameters are summarized in Tables 1, 2 and 3,
respectively.
The optimized dihedral angles of cyclohexene compare
favourably to those reported earlier as shown in Table 4;
the geometry changes with heteroatom substitution. The
increasing atomic size created by the progression from
oxygen to sulfur, then to selenium makes a noticeable
dierence, as is illustrated in Figure 7 for selected bond
length, bond angles and dihedral angles.
When both substitutions by the heteroatoms within
the ring, as well as alkyl and hydroxyl substitution on
tetralin are considered, the changes are quite complex.
Some of the tabulated results are shown in the form of a
3D-bar diagram in Figure 8.
Changes in C{C bond lengths and bond angles about
a carbon atom are influenced slightly by the nearby O, S
or Se. However, the changes are not large and their change
is not necessarily monotonic, as one would expect on the
basis of the periodic table (O!S!Se). Very often the pa-
rameter in question for sulfur is either smaller or larger
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Fig. 8. Variation of selected bond lengths, bond angles and dihedral angles as a function of heteroatom type and ring substi-
tution.
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Table 1. Optimized bond lengths for the stable conformers ( = 0) of the sixteen compounds studied at B3LYP/6-31G(d) level
of theory.
/HQJWK ; $ % & ' /HQJWK ; $ % & '
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than that for the oxygen and selenium-containing com-
pound.
Take for example bond angle 9 in Model D.
112:1 ! 111:6 ! 112:4
O ! S ! Se: (8)
Of the geometrical parameters, noting the dihedral angles,
D1 is close to 0 and D4 is close to 60; which would not
commonly be expected. D2, D3, D5 and D6 values were
plotted against the covalent radii of the heteroatoms O, S
and Se in Figure 9.
On going from the single heterocyclic ring (A) to the
next larger system where a benzene ring is fused to the
heterocycle (B) a large amplication in dihedral angles
were noticed. This amplication was followed by two con-
secutive attenuations on going from B to C and subse-
quently from C to D. Thus, the nal system (D) did not
dier much from the original (A) ring structure.
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Table 2. Optimized bond angles for the stable conformers ( = 0) of the sixteen compounds studied at B3LYP/6-31G(d) level
of theory.
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3.2 Molecular energetics
The computed total energies are summarized in Table 5.
These energy values are not comparable since each of the
sixteen molecular systems has a dierent number of elec-
trons. In order to make an energetic comparison of the
sixteen molecular structures some isodesmic reaction en-
ergy calculation should be made in order to determine
the relative stabilization or destabilization exerted by the
substituents on the basic structures. The calculations were
carried out according to equations (3{6). Stabilization en-
ergies are summarized in Table 6.
The stabilization energies reveal that oxygen and se-
lenium substitutions stabilize the ring system more or
less to the same extent. However, sulfur destabilizes (by
6 kcal/mole) the same ring system. This is particularly
clear from the last column of Table 6.
4 Conclusions
The present work shows that O and Se stabilize the fused
ring system of tocopherols more or less to the same extent,
while S destabilizes it slightly.
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Table 3. Optimized dihedral angles for the stable conformers ( = 0) of the sixteen compounds studied obtained at B3LYP/6-
31G(d) level of theory.
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Table 4. Previously reported and present optimized dihedral
angles of cyclohexene.
Previously reported∗ Present optimized∗∗
D1 0.00 −1:61
D2 −15:20 −13:87
D3 44.20 44.11
D4 −60:20 −60:47
D5 44.20 44.14
D6 −15:20 −13:90
∗Reference [8], ∗∗ B3LYP/6-31G(d).
The stabilization and relative stabilization are of the
following order:
O  Se  S
−4:82 −4:73 +1:19 (kcal mol−1)
0:00 +0:09 +6:01 (kcal mol−1):
On the basis of the present structural results it seems that
the seleno congener of vitamin E is a distinct possibility.
It remains to be seen if the energies of the red-ox re-
action mechanism follow the same sequence.
This work was supported by grants from Velocet Communica-
tions Inc., Toronto, Ontario, Canada and the National Science
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Fig. 9. Variation of selected bond lengths, bond angles and dihedral angles as a function of the heteroatom site and ring
substitution.
Table 5. Optimized total energies of the sixteen compounds studied.
Total energy (Hartree)
X A B C D
CH2 I −234:6482949 −388:3063939 −506:2415280 −581:4572576
O II −270:5443727 −424:2034064 −542:1505510 −617:3642250
S III −593:52225062 −747:1778850 −865:1177830 −940:3327840
Se IV −2594:7100207 −2748:3683314 −2866:3144144 −2941:5297229
Table 6. Stabilization energies exerted by oxygen, sulfur and selenium ring substitution as well as aromatic hydroxylation.
Stabilization energy (kcal/mol)a
X IB!IC (Eq. (3)) IC!XC (Eq. (4)) XC!XD (Eq. (5)) Total (Eq. (6)) O!X (Eq. (7))
CH2 I 0.344 − − − −
O II − −6:412 1.592 −4:820 0.000
S III − 0.428 0.759 1.188 6.008
Se IV − −5:293 0.566 −4:726 0.094
a The following component energy values were used: E(Ph−H) = −232:2486592, E(Ph−OH) = −307:4648704, E(C6H10) =
−234:6482949, E(C6H8EtMe) = −352:5867031.
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Abstract
Model compounds of a-, b-, g-, and d-tocopherol and Tocotrienol, as well as their sulphur and selenium congeners, were
subjected to density functional analysis. The mono methyl substitution either stabilized or destabilized the ring structures to a
small extent as assessed in terms of isodesmic reactions. In general, multiple methyl substitutions destabilized the ring.
Dimethyl para-substitution results in electronic stabilization and steric repulsion being nearly additive. This was not the case
for ortho-dimethyl derivatives, whereby steric repulsions dominate; the meta-substituted models reflect the same trend to a
lesser degree. Structurally, the phenolic hydroxyl orientation was approximately planar, with the hydroxyl proton oriented away
from the adjacent Me group whenever the structure permitted such an orientation.
q 2003 Published by Elsevier B.V.
Keywords: Tocopherol; Tocotrienol; Density functional theory; Methyl substitution; Orientation of phenolic OH
1. Preamble
The term ‘Vitamin E’ was introduced in 1922 [1].
Vitamin E includes two families of compounds:
tocopherols and tocotrienols (Fig. 1). Both families
consist of a chroman [benzpyrane] ring structure and
an isoprenoid sidechain, which is typical of terpenes.
The tocopherol family has saturated sidechains,
whereas the same sidechain in the tocotrienol family
has three non-conjugated double bonds. For both
families, the ring carbon atom that carries the sidechain
is a stereocentre of R configuration. The sidechain of
the tocopherols has two additional stereocentres at
the branching points, both of which are of R
configuration.
Each of these families has four homologous
members (see Table 1), labelled as a, b, g, and d.
They differ from each other in the extent of the methyl
substitution in the aromatic ring. The natural abun-
dance of the components of the Vitamin E family
varies from plant to plant [2].
The most important component of the Vitamin E
family is a-tocopherol. It is commercially available in
its synthetic form, which comes as an enantiomeric
mixture. The effectiveness of the synthetic racemic
mixture has traditionally been questioned, without
any explanation at the molecular level. Presently, we
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doi:10.1016/S0166-1280(02)00597-3
Journal of Molecular Structure (Theochem) 637 (2003) 11–26
www.elsevier.com/locate/theochem
* Corresponding author.
E-mail address: dsetiadi@fixy.org (D.H. Setiadi).
have more precise data to support this traditional
assumption [3].
Recently, the selenium analogue of a-tocopherol
(Fig. 2) has been suggested [4] as an alternative
congener which may be an effective antioxidant. For
this reason we wish to study the structure of the
chroman ring comparatively with its S and Se
congeners.
2. Introduction
2.1. Oxidative stress and Vitamin E
Oxidative stress may be the cause of aging as well
as of the origin of numerous degenerative diseases of
the human body [5]. About 5% of the inhaled oxygen
escapes the redox reactions associated with metab-
olism [6]. These by-products include the superoxide
anion ðO22 Þ; the hydroperoxyl radical (zOOH), hydro-
gen peroxide (H2O2) and the hydroxyl radical (zOH).
These ‘reactive oxygen species’ (ROS) are all very
reactive and therefore short-lived in the body.
Normally, there are natural mechanisms defending
against free radicals [7], which may be enzymatic or
non-enzymatic. If for some reason, these defense
mechanisms become weakened then the free radicals
can react with cellular structures such as DNA and
Fig. 1. General molecular structures of tocopherol and tocotrienol. aromatic substituents (R1, R2, and R3) are specified in Table 1.
Table 1
Extent of methyl substitutions of the tocopherol and tocotrienol
families
R1 R2 R3
a Me Me Me
b Me H Me
g H Me Me
d H H Me
Fig. 2. A general structure of seleno-tocopherol.
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proteins, or even destroy membranes through lipid
peroxidation [8–10]. It is generally believed that
aging and other age-related degenerative diseases
such as cardiovascular disorders and cancer can be
induced through these pathways [1]. Furthermore,
oxidation of a methionine residue has been implicated
recently [11] in Alzheimer’s disease as a result of
oxidative stress.
The potent antioxidant Vitamin E helps to prevent
cancer by blocking lipid peroxidation and sub-
sequently reduces the conversion of polyunsaturated
fats into free radicals. Lipid peroxidation is a potential
initiator not only of cardiovascular diseases but also
all forms of cancers, especially of the breast and
colon.
Vitamin E works synergistically with Vitamin C
and with the mineral selenium, with which it has a
special affinity. Selenium and Vitamin E combined
constitute a double defense against cancer. As it is not
possible to obtain optimally protective quantities of
Vitamin E from diet alone, supplements of 400–1600
international units (IU) are recommended daily. Note
that 1 mg a-tocopherol ¼ 1.49 IU.
2.2. Structural background
Since it is generally believed that the tail end of
tocopherols are only needed to enhance fat solubility
[12] it is appropriate to initially concentrate on the
fused ring systems (II, III, IV). Compound III and IV
are the sulphur and selenium containing congeners
respectively of chroman (II).
In a previous paper [13] the geometry of the
chroman ring (II) as well as its S and Se containing
congeners were studied. In the present paper, the
effect of the methyl groups introduced to the aromatic
ring will be reported. In a subsequent paper [14] the
effect of the substituents in a-position of the
heteroatom, namely methyl and ethyl, were examined
using isodesmic reactions. In the same paper, the
energetics of the aromatic hydroxation were also
investigated.
3. Method
Molecular orbital computations were carried out,
using the GAUSSIAN98 program package [15], on
three families of compounds: chromane (II), thio-
chroman (III), and selenochroman (IV). Tetralin (I)
is discussed in previous works [13,14] is omitted
here.
Eight structures, the unsubstituted and seven methyl
substituted ring structures, were considered for oxygen
(II), sulphur (III), and selenium (IV) heteroatoms in
the ring. Thus, a total of 3 £ 8 ¼ 24 structures are
reported in the present paper. Of the seven substituted
structures four are Vitamin E models (a, b, g, d) while
the remaining three (E, E*, F), two single and one
double methylated ring, respectively, have no relation
to Vitamin E.
The definition of the spatial orientation, as well as
the numbering of the constituent atomic nuclei, are
shown in Fig. 3. The input files were numerically
generated, whereby visualization tool was used for
this purpose.
Two methods and 2 split-valence basis sets were
used, mainly the RHF/3-21G, RHF/6-31G(d) and the
B3LYP/6-31G(d) levels of theory. Convergence
criteria of 3.0 £ 1024, 4.5 £ 1024, 1.2 £ 1023, and
1.8 £ 1023 were used for the gradients of the root
mean square (RMS) Force, Maximum Force, RMS
Displacement and Maximum Displacement vectors,
respectively. However, only the B3LYP/6-31G(d)
results are reported in the present paper.
The stabilization or destabilization exerted by the
methyl groups attached to the aromatic ring were
studied through isodesmic reactions in which the Me
group was transferred from toluene to the aromatic
ring of the chroman skeleton, as well as its sulphur
and selenium congeners. These isodesmic reactions
are shown in Fig. 4. The following B3LYP/6-31G(d)
energy values were used for toluene and
benzene: (2271.56662) and (2232.248659) hartrees
respectively.
4. Results and discussion
4.1. Molecular geometries
A total of twenty-four compounds were sub-
jected to geometry optimizations. Of that total each
of the oxygen, sulphur, and selenium containing
rings had 8 homologues containing 0, 1, 2 and 3
methyl groups attached to the aromatic ring.
D.H. Setiadi et al. / Journal of Molecular Structure (Theochem) 637 (2003) 11–26 13
Fig. 3. Structures of the 3 £ 8 ¼ 24 molecules studied.
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These twenty-four structures are shown in Fig. 3
together with their atomic numbering system.
For the tabulation of the optimized geometrical
parameters the bond lengths, bond angles, and
dihedral angles, for X ¼ O, S and Se are shown in
Fig. 4. These parameters are summarized in
Tables 2–4, respectively.
The structures of the triple methylated aromatic
ring (a-homologues) for the O, S and Se congeners
are shown in Fig. 5. The hydroxyl group (OH) was
Fig. 4. Isodesmic reactions for the incorporation of aromatic methyl substituents.
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Table 2
Optimized bond lengths of the 24 structures studied
D.H. Setiadi et al. / Journal of Molecular Structure (Theochem) 637 (2003) 11–2616
T
ab
le
3
O
p
ti
m
iz
ed
b
o
n
d
an
g
le
s
o
f
th
e
2
4
st
ru
ct
u
re
s
st
u
d
ie
d
(c
o
n
ti
n
u
ed
o
n
n
ex
t
p
a
g
e)
D.H. Setiadi et al. / Journal of Molecular Structure (Theochem) 637 (2003) 11–26 17
D.H. Setiadi et al. / Journal of Molecular Structure (Theochem) 637 (2003) 11–2618
Table 4
Optimized dihedral angles of the 24 structures studied
Model X D(3–2–
1–6)
D4 D5 D6 D(1–6–
5-4)
D7 D(10–1–
2–3)
D(8–7–
6–1)
D9 D(10–9–
8–7)
D(1–10–
9–8)
D(6–1–
10–9)
D8
D II(O) 0.17 0.17 20.37 0.20 0.14 2179.77 178.49 216.77 44.81 258.22 43.10 215.77 163.13
D III(S) 20.91 0.94 20.29 20.41 0.44 178.74 176.78 219.56 53.48 265.15 42.74 217.02 162.22
D IV(Se) 20.81 0.55 20.03 20.24 20.03 178.40 178.13 216.03 53.45 267.51 45.10 217.53 165.64
E II(O) 20.10 0.80 20.53 20.48 1.17 2178.87 178.47 215.30 43.78 257.92 43.83 216.35 164.73
E III(S) 20.49 1.07 21.00 21.05 1.62 179.99 177.75 215.35 50.75 265.58 45.17 217.71 166.32
E IV(Se) 21.04 1.30 20.33 21.00 1.15 179.94 178.43 212.73 51.44 267.59 46.35 218.22 168.53
E* II(O) 0.38 0.08 20.39 0.25 0.20 2179.56 178.67 216.61 44.77 258.31 43.01 215.49 163.15
E* III(S) 20.21 0.33 20.11 20.24 0.36 178.69 177.60 217.97 52.32 265.61 44.02 216.87 163.79
E* IV(Se) 20.79 0.58 20.07 20.22 0.04 178.48 178.29 216.09 53.53 267.46 44.84 217.11 165.57
F II(O) 0.69 0.56 20.52 20.42 0.22 2178.68 179.09 216.62 43.10 258.35 42.93 215.08 165.85
F III(S) 0.30 0.95 20.26 21.03 0.35 2180.03 178.22 219.38 50.19 264.89 42.12 214.49 167.12
F IV(Se) 20.09 0.88 20.14 20.90 0.04 2180.08 178.78 216.85 51.02 267.04 43.94 215.94 168.99
G(d) II(O) 0.33 20.08 20.46 0.38 1.30 2179.50 179.01 214.12 45.05 258.50 45.09 217.08 163.09
G(d) III(S) 20.38 0.14 20.35 0.09 1.60 178.98 178.06 214.57 53.76 265.86 45.82 218.11 162.05
G(d) IV(Se) 20.67 0.16 20.14 0.03 1.05 178.67 178.77 212.18 54.26 267.72 46.69 218.45 164.61
H(g) II(O) 0.05 0.48 20.65 0.28 0.25 180.41 178.22 216.57 44.67 216.57 258.43 216.36 163.26
H(g) III(S) 0.71 0.01 20.50 0.29 0.43 179.21 178.45 219.39 53.90 219.39 265.01 214.11 161.91
H(g) IV(Se) 20.31 0.59 20.47 0.06 0.23 178.96 178.19 218.59 55.51 218.59 266.50 214.59 162.77
I(b) II(O) 1.16 0.02 20.58 20.04 1.19 2178.64 179.67 214.51 43.76 214.51 258.48 216.11 165.31
I(b) III(S) 0.63 0.55 20.62 20.52 1.68 2179.42 179.22 215.13 51.42 215.13 265.61 215.66 165.98
I(b) IV(Se) 0.06 0.64 20.44 20.47 1.15 2179.83 179.62 212.71 51.81 212.71 267.40 216.87 168.31
J(a) II(O) 20.26 1.35 21.06 20.40 1.46 2178.76 178.32 214.04 42.84 258.47 46.24 218.20 166.18
J(a) III(S) 20.94 1.97 21.59 20.38 2.70 2179.14 177.16 215.07 51.46 265.31 45.20 216.77 168.67
J(a) IV(Se) 20.48 1.99 21.61 20.36 1.89 2179.17 178.71 212.44 51.45 267.32 46.16 217.08 168.67
Model X D(9–10–
1–2)
D10 D12 D13 D14 D15 D16 D17 D18 D19 D23 D24 D30
D II(O) 165.98 2178.52 2179.93 2179.82 2179.44 41.49 274.76 274.70 167.57 2172.28 62.36 2179.94 179.79
D III(S) 166.43 2177.28 2179.61 179.65 179.88 39.98 274.40 268.87 174.83 2179.41 57.01 173.70 179.88
D IV(Se) 163.59 2178.32 2179.82 179.86 179.78 43.17 270.37 269.27 174.92 178.89 53.19 179.19 2179.82
E II(O) 165.14 2179.35 2179.71 2179.60 179.83 43.30 272.49 275.67 166.76 2171.84 62.75 2179.11 21.63
E III(S) 164.16 2178.92 2179.73 179.46 179.15 44.27 269.54 271.63 172.37 2179.73 56.47 174.30 20.63
E IV(Se) 162.34 2179.63 2179.62 179.46 179.13 46.26 266.81 271.40 173.10 2178.90 53.19 2179.30 20.47
E* II(O) 166.28 2178.67 2179.99 179.86 2179.35 41.62 274.73 274.67 167.55 2172.35 62.34 2179.90 179.76
E* III(S) 165.45 2177.75 2179.85 179.86 179.99 41.53 272.83 269.93 173.72 2179.85 56.53 173.63 2179.93
E* IV(Se) 163.85 2178.55 2179.72 179.85 179.81 43.17 270.48 269.22 174.95 178.93 53.33 179.01 2179.85
F II(O) 166.57 2179.84 2179.78 179.77 179.93 44.41 271.50 276.25 166.11 2172.39 62.11 2179.41 23.06
F III(S) 167.67 2179.20 2179.64 179.57 179.13 44.99 268.86 272.13 171.81 180.00 56.17 174.40 21.40
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almost always coplanar with the aromatic ring
(within ^ 3 degrees), deviating at most up to ^ 7
degrees as a result of the steric ‘congestion’ arising
from the six-fold substitution on the benzene ring. The
orientation of the OH was such that it pointed away
from the adjacent CH3 group, whenever the structure
would permit. Table 4 shows this in column D30, with
an optimized anti-orientation for the OH in models D,
E*, G(d) and H(g) and a syn-orientation in models E,
F, I(b) and J(a), irrespective of the starting
orientation.
The variables in Tables 2 and 3 also show
structural trends, whereby the C–C bonds adjacent
to the C carrying the Me substitution are lengthened,
irrespective of heteroatom substitution. In contrast,
the bond angles change with heteroatom substitution,
irrespective of Me substitution; summarized in
Table 3. Several other structural trends of smaller
magnitude are also apparent but not elaborated
upon here.
4.2. Molecular energetics
The computed total energies are summarized in
Table 5. The energies of stabilization calculated
according to the scheme given in Fig. 6 are tabulated
in Table 6. The graphical representation of these
results is shown in Fig. 7.
A comparison of the relative activity of z-
tocopherols ðz ¼ a;b; g; dÞ as measured by
ln{½Az=½Aa} may be calculated using the calculated
energy of stabilization (DEz).
ln{½Az=½Aa} ¼ FðDEzÞ
The numerical values are given in Table 7. Such a
plot, shown in Fig. 8, suggests that there may be an
exponential relationship interconnecting either one, or
both, of the paths shown below:
d! g! a
d! b! a
For this reason the relationship is converted to the
following form:
y ¼ 1:02 ln{½Az=½Aa} ¼ f ðDDEzÞ ¼ f ðxÞ
where x ¼ DDEz ¼ DEa 2 DEzTa
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Fig. 5. Numbering of bond lengths, bond angles and dihedral angles for the eight structures investigated. X may be O, S or Se.
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The exponential function obtained for the first
(d! g! a) of these two paths is shown in Fig. 9.
While the fit shown in Fig. 9 was fairly good ðR2 ¼
0:99Þ; the other path (d! b! a) did not allow a fit
to a reasonably good exponential function. With
respect to the exponential fit obtained for the
d! g! a, it seemed that b was estimated to be
less stable by 1.750 kcal mol21.
While we have no explicit structured explanation
for this derivation, it should be pointed out that the
two methyl groups in the b form are in para-position
with respect to each other. This would suggest that
any electronic effects the Me-groups might exert on
the aromatic ring would be cancelled, or nearly
cancelled, by vectorial addition. For this reason, we
collected all the computed dipole moments in Table 8,
which is hoped to reveal the polarity of the various
forms.
This data reveals that homologous E, F, b, and a
have dipole moments less than 1 Debye due to partial
cancellation of electronic effects while homologous
D, E*, d and g have dipoles over 2 Debye. This is the
case for all three congeners.
The question of arithmetical additivity in the
stabilization or destabilization effects of these Me-
groups on the chroman ring and its congeners has to
be examined at least in passing. The results are shown
in Table 9.
It appears that the stabilization energies are not
additive, indicating that in addition to the electronic
effects, steric ‘congestion’ occurs when the methyl
groups are proximally introduced. Such an obser-
vation has been noted by Hammett [16] in studying
chemical reactivity. When the substituents were far
away from the reaction site, good correlation was
observed between reactivity and structure.
Alternatively, when substituents were placed in an
ortho-position, the points scattered randomly and
did not correlate at all. Thus, the Hammett’s linear
free-energy relationship is valid only when the
substituents are far away from the reaction site.
For the I(b) isomers, where the two Me-groups
are in para-position with respect to each other,
Table 5
Total energies (hartrees) computed for the 24 optimized structures
II(O) III(S) IV(Se)
D 2617.36422 2940.33278 22941.52972
E 2656.68052 2979.64832 22980.84517
E* 2656.68287 2979.65164 22980.84873
F 2695.99823 21018.96614 23020.16312
G(d) 2656.68269 2979.65015 22980.84932
H(g) 2695.99754 21018.96431 23020.16386
I(b) 2695.99890 21018.96543 23020.16461
J(a) 2735.31221 21058.27721 23059.47685
Fig. 6. Three optimized structures of the shortened sidechain model
of the a-tocopherol.
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Table 6
Energy of stabilization associated with single or multiple methyl group transfers
II(X ¼ O) III(X ¼ S) IV(X ¼ Se)
Single step Accumulated steps Single step Accumulated steps Single step Accumulated steps
XD ! XE 1.043 1.043 1.520 1.520 1.576 1.576
XD ! XE* 20.430 20.430 20.562 20.562 20.658 20.658
XE ! XF 0.161 1.204 0.090 1.610 0.007 1.583
XD ! XG(d) 20.320 20.320 0.372 0.372 21.028 21.028
XG(d) ! XH(g) 1.952 1.633 2.386 2.759 2.147 1.118
XG(d) ! XI(b) 1.100 0.781 1.684 2.056 1.676 0.648
XI(b) ! XJ(a) 2.918 3.699 3.879 5.934 3.587 4.235
Fig. 7. Computed stabilization energies.
Table 7
Relative biological activity of tocopherols and computed stabilization energy values of model compounds
Relative activitya Computed stabilization energy
z-tocopherol [Az]/[Aa] ln{[Az]/[Aa]} 1-ln{[Az]/[Aa]} DEz DDEz ¼ DEa 2 DEz
a 1.000 0.000 0.000 3.698 0.000
b 0.570 20.562 1.562 0.780 2.918
g 0.370 20.994 1.994 1.634 2.054
d 0.014 24.269 5.269 20.318 4.016
a Activities were taken from Ref. [3], also quoted in Table 3 of Ref. [13].
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the discrepancy is within 0.2 kcal mol21. For the F
isomers, where the Me groups are in meta-position
with respect to each other, the discrepancy is within
0.7 kcal mol21. In these two cases the Me groups are
virtually independent of each other. However, when
two Me groups are in an ortho-orientation, the
discrepancy is 4.3 kcal mol21, indicating that steric
destabilizing congestion dominates over electronic
stabilizing effects.
Fig. 8. Relative activity of tocopherol vs stabilization energies of tocopherol model.
Table 8
Dipole moments of optimized structures
Homologue II(O) III(S) IV(Se)
lml (Debye) lml (Debye) lml (Debye)
D 2.7878 3.0528 2.9677
E 0.5764 0.8893 0.8484
E* 2.4686 2.8062 2.7313
F 0.436 0.8416 0.8323
G(d) 2.6586 2.7262 2.6327
H(g) 2.3264 2.4493 2.3562
I(b) 0.7322 0.5561 0.5327
J(a) 0.6622 0.6971 0.6876Fig. 9. Modified relative activity of tocopherol vs relative
stabilization energies of tocopherol model.
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5. Conclusions
Both Me and heteroatom substitution change the
molecular structure of Vitamin E, in terms of bond
lengths, bond angles and dihedral angles. The effect of
Me substitution was observed predominantly in the
case of adjacent bond lengths, while heteroatom
substitution influenced bond angles and dihedral
angles.
With the exception of the model of b-tocopherol,
where the 2 introduced Me groups ( para-oreintation)
nearly cancel their electronic contribution and
provide little steric congestion, a general trend was
observed with increasing substitution in the follow-
ing sequence d! g! a. The structural contribution
is measured by the relative stabilities in kcal mol21
units, with d being the most stable and a being the
least stable. This trend correlated with the logarith-
mic relative activity of the Vitamin E homologues d,
g and a, respectively.
This clearly indicates that there is a structural basis
for the differing biological activity of the naturally
occurring Tocopherol homologues.
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Abstract
The free radical scavenging mechanism, leading to a quinodal structure via an oxidative ring opening is exothermic.
However, the ionic oxidative ring opening is endothermic. Consequently, the ionic reductive ring closing must be exothermic.
This leads to the suggestion that Vitamin E may be recovered, unchanged, thus effectively acts as a catalyst for the following
reaction
2HOOz þ H3OðþÞ þ NADH! 2HOOH þ H2O þ NADðþÞ; DE < 2120 kcal mol21:
As Vitamin E is biologically recycled, a single a-tocopherol molecule may convert numerous HOOz radical to H2O2 which is
accumulated if not removed at the same rate, enzymatically, with the participation of catalase (Fe) or glutathione peroxidase,
GPx(Se). This accumulation of peroxide, which may be referred to as a ‘peroxide traffic jam’, may well be the reason of the pro-
oxidant effect of Vitamin E.
q 2002 Published by Elsevier Science B.V.
Keywords: Vitamin E; Pro-oxidant; Anti-oxidant; Free radical oxidative ring opening; Ionic reductive ring closing; Biological recycling of
Vitamin E; Vitamin E as a catalyst
1. Preamble
1.1. The nature of oxidative stress
Since chemical reactions are usually not quantitat-
ive, up to 5% of the oxygen we inhale may be
converted to ‘reactive oxygen species’ (ROS) [1].
During normal metabolism, as food is oxidized in
0166-1280/03/$ - see front matter q 2002 Published by Elsevier Science B.V.
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the living cells, oxygen is being reduced to water. The
reduction (1) is a multi-step process; the intermediate
stages correspond to the ROS
O2! Ozð2Þ2 ! HO–Oz! HO–O :ð2Þ !H2O2
! · · ·! HOz! H2O:
ð1Þ
When any of these ROS escape from this sequence of
reductive reactions, they may damage internal struc-
tures of the cell including DNA, RNA and various
proteins, in addition to the cell membrane. Such
damage also leads to degenerative diseases, as well as a
weakened immune system [2].
As an educated guess, we might say that in
every human being, ROS may strike and damage
each single DNA molecule, perhaps as many as
10,000 times a day. To prevent the propagation of
mutations, approximately 99% of the damaged
DNA strands may be restored by DNA repair
enzymes. The remaining 1% escapes the repair
action of the enzymes, leaving approximately 100
damaged strands of DNA in the system. Lipid
peroxidation may also cause great damage [3–5].
All of these damages can accumulate over time,
eventually causing atherosclerosis, cancer and other
degenerative diseases such as Parkinson’s and
Alzheimer’s diseases.
The body has two types of mechanisms to
eliminate ROS before they assert any damage.
These include
(i) Enzymatic reductions of ROS beyond the regular
process,
(ii) Scavenging of ROS by anti-oxidant compounds.
With advanced age, both of these mechanisms fight
a losing battle against ROS. However, even at a
younger age, the ammunition for these anti-oxidant
mechanisms must come from a healthy diet, which is
not always practiced or available. In such cases, the
‘healthy diet’ does include dietary supplement.
Needless to say, it is important that young people
acquire a vigilant attitude concerning their diets in
order to reap the long-term benefits.
1.2. Essential nutrient components
Both of the above two mechanisms to fight ROS
require special nutrients.
For mechanism (i), it may be some trace
element such as magnesium, vanadium, chromium,
manganese, iron, copper, zinc or selenium (Mg, V,
Cr, Mn, Fe, Cu, Zn, or Se) that may be needed at
the active site of some enzyme. If these trace
elements are not available, mechanism (i) would
not be operative. For example, the natural selenium
(Se) level in the soil is highly variable. It is
common knowledge that in the USA, the Eastern
Coastal Plain and the Pacific Northwest have the
lowest levels of Se. In these areas, the daily Se
intake of the population is in the range of 60–
90 mg. In contrast, in areas rich with Se, the range
of daily Se intake is 60–200 mg. The average daily
US intake is approximately 125 mg. Those living
where the highest levels of Se exist also have the
lowest levels of lung, colon, bladder, pancreas,
breast and ovarian cancers. Thus, if the soil is
depleted of Se, then the vegetation will not have an
adequate amount of Se, and the local diet would
reflect the low Se content. The recommended daily
intake should be in the vicinity of 300 mg. It may
well be that the diet of the whole North American
continent is too low in Se. This may be responsible
for North Americans having some of the highest
worldwide levels of degenerative ailments such as
cancer and cardiovascular diseases as well as
Alzheimer’s and Parkinson’s diseases. Of course,
an overdose of Se is dangerous, but is not expected
to happen unless the daily intake reaches 1000 mg.
Selenium is at the active site of glutathione
peroxidase, incorporated in the form of selenocys-
tein [6]. Mechanistically, selenium acts as a
temporary oxygen carrier [7], consequently, by
any definition, it is a catalyst as shown in Fig. 1.
Thus, while selenium is used at the active site of
glutathione peroxidase (GPx), other trace metals are
also important. For example, Cu and Zn are
cofactors of most superoxide dismutase (SOD).
However, some SOD molecules contain manganese
(Mn), iron (Fe) or even nickel (Ni). Also, while
most catalase enzymes usually contain Fe in a
heme, on occasion some catalase molecules will
operate with the help of Mn.
For mechanism (ii), certain vitamins (like C and E)
act as anti-oxidants in the battle against ROS. Vitamin
C is water soluble and therefore functions in
the aqueous phase, while vitamin E is fat soluble,
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functioning in lipid bilayers and in lipoprotein
micelles.
Numerous other anti-oxidants (such as lycopene,
b-carotene, flavones, farnesol, allyl-methyl-disulfide,
lipoic acid, coenzyme Q10 or ubiquinone, etc.) are also
needed [8,9]. Plants produce these anti-oxidants and
fruits and vegetables are expected to supply them.
However, the level of these anti-oxidants in fruits and
vegetables may vary not only according to the
geographical location where they were produced as
well as the method of production, but also vary from
season to season, or with distance of transportation.
Consequently, anti-oxidants may now have to be
added to the food items or must be provided as a
supplement in order to produce a healthy diet. If
regular foodstuff was sufficiently nutritious, or if
dietary supplements were included in meals, the
incidence of degenerative diseases may be reduced
substantially, which in turn could considerably lessen
health care costs.
2. Introduction
It is generally accepted that reduction of morbidity
and mortality from cardiovascular disease is associ-
ated with an increase intake of anti-oxidant vitamin E
and vitamin C. This apparent cause – causality
relationship has been explained on the basis of
oxidative modification of low density lipoprotein
(LDL). The corollary of this assumption is that the
inhibition of lipid peroxidation in LDL, by vitamin E,
leads to the reduction of myocardial infarction and
stroke. Numerous papers testify along this line
[10–12].
In the mean time, not only does vitamin E
behave as a non-anti-oxidant [13] but pro-oxidant
[14] effects of vitamin E have also been demon-
strated. The fact that vitamin E can act as both
anti-oxidant and pro-oxidant has led to the point
that vitamin E has come to know as a ‘Janus
molecule’ [15].
The free radical oxidation products of a-
tocopherol have been analyzed by Liebler et al.
[16] in 1996 showing more other extensively
oxidized products than the quinoidal structure.
The ionic mechanism was suggested by Roseman
et al. [17] in 1999 which has led to the quinoidal
structure. These mechanisms were also reviewed
recently by Brigelius-Floke and Traber [18].
Under strong oxidative conditions vitamin E
may undergo progressively more extensive oxi-
dation that could lead to irreversible metabolization
of the tocopherol molecule. Such a destructive
oxidation [16], leading to a variety of epoxide,
which may metabolize even further is shown in
Fig. 2. Note that the steps at the left hand column
in Fig. 2 are non-destructive as it corresponds to
the formation of the quinone–hydroquinone ana-
logue of vitamin E. Nevertheless, there exists an
ionic oxidative mechanism of a-tocopherol leading
to quinoidal or even to hydroquinone structure.
Such a mechanism [17] is shown in Fig. 3.
However, even here, some side reactions may
occur. The left hand column of Fig. 3 shows the
non-destructive process.
3. Scope
The present paper raises more questions than
can be answered at this time, related to the
dichotomy of the anti-oxidant as well as pro-
oxidant nature of vitamin E.
Of course one may argue that the anti-oxidant and
pro-oxidant natures of vitamin E depends on the redox
Fig. 1. A schematic mechanism of action for glutathione peroxidase
(GPx). The Se-deprotonated GPx is denoted at the top on E–Se
(2 )
selenolate. Reduced and oxidized glutathione are denoted as GSH
and GSSG, respectively.
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potential. In turn, the redox potential varies according
to the Nernst equation (2)
E ¼ E0 2 RT =n ln{½Red=½Ox} ð2Þ
where n is the number of electrons transferred and
the expression [Red]/[Ox] measures the ratio of
reduced and oxidized forms.
Nevertheless, it seems plausible to seek expla-
nation at the molecular level concerning the ‘traffic’
which is passing through the overall reduction
presented in Eq. (1). Sufficient computed results are
presented to provide theoretical backing to the merit
of the questions to be asked and some putative
mechanistic answers suggested.
Fig. 2. A schematic mechanistic representation of non-destructive and destructive free radical oxidation of a-tocopherol by HOOz.
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4. Method
The definition of the relative spatial orientation as
well as the numbering of the constituent atomic nuclei
are shown in Fig. 3. The input files were numerically
generated. No visualization tool was used for
this purpose. GAUSSIAN 98 [19] calculations were
carried out at the B3LYP/6-31G(d) levels of theory
(Fig. 4).
For the hydride abstraction three different cations
were investigated according to mild, medium and
strong hydride affinity. The computed energies
necessary for balanced reactions are summarized in
Table 1. On the basis of the computed hydride
affinities (Table 1) it seems that the H(2 ) affinity of
pyridium ion is numerically close to that of Li(þ ). For
this reason instead of NADH, at least on energetic
grounds, Li–H may be used as a hydride donor. The
computed total energies for both radical and ionic
reactions are listed in Table 2.
5. Results and discussion
5.1. Molecular geometries
In the ionic mechanism, only compounds labeled
1 and 5; have unsaturated benzenoid rings.
Fig. 3. A schematic mechanistic representation of non-destructive and destructive ionic oxidation of a-tocopherol.
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Fig. 4. Atomic numbering system of reactant, reaction intermediates and product of free radical and ionic oxidation of a-tocopherol.
Table 1
Energy components and hydride affinities for hydride abstraction as computed at the B3LYP/6-31G(d) level of theory
Cation E (Hartree) Neutral E (Hartree) Hydride affinity (kcal mol21)
Li(þ ) 27.284544 LiH 28.081922 210.570
C5H6N
(þ ) 2248.6569798 C5H7N 2249.455315 211.17
CH3
(þ ) 239.480388 CH4 240.518383 361.56
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The intermediates labeled as 2 and 3 and the product
molecule labeled as 4; have quionoidal bonding.
However, the quinoidal structure for 4 can clearly be
seen in Fig. 5 and compared to the original vitamin E
model 1: In the free radical mechanisms reactant is
labeled as I, intermediates as II and IIp, while the
products are specified as III and IV: Clearly 1 ¼ I;
3 ¼ III and 4 ¼ IV:
5.2. Mechanism and molecular energetics
The free radical and ionic as well as an ionic
mechanism studied in the present paper are is shown
in Scheme 1.
5.2.1. Radical mechanism
Fig. 6 shows the energy profile for the free
radical mechanism on the basis of the data
presented in Table 3. The energies of water and
oxonium ions necessary for the mechanism are
shown in Table 2. The thermodynamic reaction
profile showing only energy minima, allows a
down-hill process, in the thermodynamic sense.
Consequently, the radical scavenging ability of a-
tocopherol is well established on energetic grounds.
The reaction is balanced from reactant ðIÞ to the
first ionic product ðIIIÞ, as shown in Eq. (3)
The overall amount of energy released is 2 32.49
kcal·K
While the first step, the hydrogen abstraction, may
occur by either HOzor HOOz attack, the energetics is
expected to be considerably more exothermic, by
about232.4 kcal·K with the HOz radical than with the
HOOzradical
ð4Þ
However this would only underline the validity of
the conclusion reached with the use of the HOOz
radical.
5.2.2. Ionic mechanism
The relative energies necessary to construct a
thermodynamic reaction profile for the ionic reac-
tions are summarized in Table 4. The thermodyn-
amic reaction profile (only energy minima, without
the appropriate transition states) are shown in Fig. 6
for a-tocopherol. The energies of water and
oxonium ions necessary for the mechanism are
shown in Table 2.
It should be emphasized that the first step involves
a hydride acceptor. In biological systems it is
NAD(þ ). However no full computations have been
accomplished at the DFT level for the NAD(þ )/-
NADH system. Protonated pyridine gives hydride
affinity close to that of Li(þ ) therefore this model
appears to be fairly realistic for NAD(þ ), at least on
energetic grounds.
The reaction was balanced from the reactant ð1Þ to
the first ionic product ð3Þ as shown in Eq. (5), using
Li(þ ) instead of NAD(þ )
ð3Þ
ð5Þ
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The overall amount of energy released is
þ85.35 kcal·k.
It is clear from Fig. 7 that the steps are all
endothermic. This indicated that the ionic mechan-
ism is unlikely to occur. However, the reverse,
namely the reduction back from the oxidized a-
tocopherol (i.e. a-tocopherolquinone) to the original
a-tocopherol would be expected to be an exother-
mic process (Table 5). Thus, it seems that the
oxidation proceeds by the free radical mechanism
while the reductive conversion, back to a-toco-
pherol would be expected to proceed by the ionic
mechanism. This combined mechanism is shown in
Fig. 8 (Table 6).
It is believed that the coupled nature of the
radical and ionic oxidation is shown, for the first
time, here in Fig. 8. The energy profile for the
combined mechanism is shown in Fig. 9.
Since a-tocopherol has been used but not
consumed in the coupled reaction, a-tocopherol
may be regarded as a catalyst for the following
overall processes
2HOOz þ H3OðþÞ þ NADH! 2HOOH þ H2O
þ NADðþÞ; DE ¼ 2120:18 kcal·k ð6Þ
The essential point is, however, that a-tocopherol
can only convert the peroxyradical only to hydro-
gen peroxide [H2O2] but not further. From that
point onward, it is the job of the enzyme
glutathione peroxidase GPx(Se) or Catalase(Fe) to
carry the process further through the full reduction
to H2O.
A schematic illustration of the overall process
involving the various enzymes and non-enzymatic
anti-oxidants is shown in Scheme (2).
The catalytic nature of vitamin E is shown in
Fig. 10. Clearly, if vitamin E was destroyed at the
end of the first step it could not produce more
peroxide. Thus, under such condition its pro-
oxidant nature perhaps would not ever have been
ever observed. However, vitamin E is recycled,
biologically, as Fig. 10 indicates and a single a-
tocopherol molecule may convert numerous HOOz
radicals to H2O2 which is accumulated if not
removed at the same rate enzymatically with the
participation of Catalase(Fe) or glutathione peroxi-
dase, GPx(Se). This accumulation of peroxide,
which may be referred to as a peroxide traffic
jam, may well be the reason of the pro-oxidant
effect of vitamin E.
Table 2
Energy components, necessary to balance the redox reactions,
computed at the B3LYP/6-31G(d) level of theory
Species E (Hartree) Species E (Hartree)
E(H2) 20.461817 E(HOOz) 2150.899156
E(HOz) 275.723455 E(HOO2) 2151.462597
E(H2O) 276.408953 E(HOOH) 2151.532085
E(H3O
þ) 276.685908 E(HOOLi) 2158.503570
Fig. 5. Structures of a-tocopherol (top) and a-tocopherolquinone
corresponding to reduced [Red] and oxidized [Ox] forms,
respectively, in Eq. (2). All aromatic CC bond lengths in the top
structure are in the vicinity of 1.40 A˚. The single and double bond
lengths in the ring of the bottom structures are in the vicinity of 1.49
and 1.35 A˚, respectively.
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Scheme 1.
Fig. 6. Reaction profile of non-destructive free radical oxidation of a-tocopherol model by HOOz.
Table 3
Total energy values of a-tocopherol model and its oxidized forms computed at the B3YP/6-31G(d) level of theory
Reactant,
intermediates, product
E (Hartree)
Free radical route Ionic route
Reactant I 2735.31212 1 2735.31212
Closed ring intermediate II 2734.69317 2 2734.45881
Closed ring intermediate IIp 2885.63012 –
Open ring intermediate III 2810.84221 3 2810.84221
Product IV 2810.51082 4 2810.51082
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Table 4
Total and relative energies for the free radical mechanism
Route State E (Hartree) DE (kcal ·K) DDE (kcal ·K)
Neutral I þ 2HOOz þ H3Oþ þ H2O 21190.205294 0.000 0.000
II þ HOOz þ HOOH þ H3Oþ þ H2O 21190.219272 28.771 28.771
IIp þ HOOH þ H3Oþ þ H2O 21190.257066 232.487 223.716
III þ 2HOOH þ H2O 21190.315332 269.050 236.563
IV þ 2HOOH þ H3Oþ 21190.260897 234.892 34.159
Fig. 7. Reaction profile for ionic oxidation mechanism using Li(þ ), a hydride abstractor modeling NAD(þ ).
Table 5
Total and relative energies for the ionic mechanism
Hydride abstraction initiator State E (Hartree) DE (kcal ·K) DDE (kcal ·K)
Liþ 1 þ Liþ þ 2H2O 2895.414570 0.000 0.000
2 þ LiH þ 2H2O 2895.358638 35.098 35.098
3 þ LiH þ H2O 2895.333085 51.133 16.035
4 þ LiH þ H3Oþ 2895.278650 85.291 34.159
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Fig. 8. The connection of a combined non-destructive free-radical and reversible ionic mechanism of oxidation of a-tocopherol quionone. Note
the reversible nature of the ionic process.
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Table 6
Total and relative energies for the combined mechanism of free radical oxidation and ionic reduction
Components structures E (Hartree) Sum of component
energies (Hartree)
Relative energy DE (kcal·K) Step height energy DDE (kcal·K)
I ¼ 1 2735.31212 21121.87826 0.000 0.000
2(HOOz) 2301.79831
H3O
(þ ) 276.68591
LiH 28.08192
Total 21121.87826
II 2734.69317 21121.89224 28.771 28.771
HOOH 2151.53208
HOOz 2150.89916
H3O
þ 276.68591
LiH 28.08192
Total 21121.89224
IIp 2885.63012 21121.93003 232.487 223.716
HOOH 2151.53208
H3O
(þ ) 276.68591
LiH 28.08192
Total 21121.93003
IIIðþÞ ¼ 3ðþÞ 2810.84221 21121.98830 269.050 236.563
2(HOOH) 2303.06417
LiH 28.08192
Total 21121.98830
2ðþÞ 2734.45881 21122.01385 285.085 216.035
2(HOOH) 2303.06417
H2O 276.40895
LiH 28.08192
Total 21122.01385
1 2735.31212 21122.06979 2120.183 235.098
2(HOOH) 2303.06417
H2O 276.40895
Li(þ ) 27.28454
Total 21122.06979
Fig. 9. Full cycle of reaction mechanism involving free radical open shell oxidation and closed shell recovery of a-tocopherol. The energy
difference between initial and final states is related to the process: 2HOOz þ Li–H! HOOH þ HOOLi:
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6. Conclusions
If vitamin E reacts with HOz radical then the radical
is converted to H2O which represents no further
problem, as it is the last station of the overall reductive
process which started at O2. However, when vitamin
E reacts with HOOz then the peroxyradical is
converted to hydrogen peroxide (H2O2) which could
cause oxidative damage.
The present investigation has shown that a
substantial fraction of the oxidized vitamin E may
be reduced back to active vitamin E which could, in
turn, produce more hydrogen peroxide. The
responsibility of removal of the hydrogen peroxide
from the system bestowed upon two enzymes, the iron
containing catalase (Fe) and the selenium containing
glutathione peroxidase, GPx(Se). If there is a notice-
able concentration reduction of these enzymes then
peroxides are accumulating, leading to a peroxide
traffic-jam. This can happen for example if the Se
supply is low, as discussed at the beginning of this
paper. Of course, the accumulated H2O2, produced by
vitamin E, can make a great deal of damage and
consequently vitamin E may well be misjudged to be a
pro-oxidant yet the phenomenon may be due to the
low level of selenium.
It now appears that future clinical studies, designed
to investigate the efficacy (the anti-oxidant effect) and
the toxicity of the accumulated peroxide (via the pro-
oxidant effect) of vitamin E should include the
monitoring of other participating components of the
detoxification process of ROS. Such studies should
include the monitoring of the level of catalase (Fe or
Mn) as well as glutathione peroxidase (Se). Nutri-
tionists [20] and biochemists [21] have already
questioned whether the imbalance of these enzymes
could be a significant contributor to the damages
originated from oxidative stress.
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Abstract
Preliminary results for a full and comprehensive study of the tocopherol family of compounds. Previous studies have allowed
for the full modelling of a-tocopherol as well as its S and Se containing congeners to be subjected to ab initio [RHF/3-21G and
RHF/6-31G(d)] and DFT [B3LYP/6-31G(d)] computation. Molecular geometries with full optimized total energies were
determined. Initial discussion for trends of the side-chain, which has included computation of helical tails as well as the effect
on ring stabilities is also investigated.
q 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Vitamin E [1] is made up of two families of
compounds: tocopherols and tocotrienols [2]. Both
families consist of a chroman [benzpyran] ring
structure and a side-chain. The side-chain has the
characteristics of an isoprenoid skeleton, typical of
terpenes with some members of the tocopherol
families having saturated side-chains. There are also
methyl substituted homologues of tocopherol which
can be seen in Fig. 1. There also exists eight different
stereo isomers for each homologue of tocopherol with
known different activities associated to them.
Past molecular computational studies have con-
centrated on the fused ring system and the different
stabilities associated with hetero-atom substitution of
the chroman molecule. It has also been suggested [3]
that the selenium congener of a-tocopherol (may be a
very effective antioxidant. The ring-closing and ring-
opening mechanisms and transition states of ring
structure was also investigated.
It has also been suggested that in a biological
system where vitamin E is recycled, a single a-
tocopherol molecule may convert numerous HOOz
radicals to H2O2 [4]. This accumulation of peroxide
0166-1280/$ - see front matter q 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.theochem.2003.08.051
Journal of Molecular Structure (Theochem) 666–667 (2003) 439–443
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molecules may be referred to as a ‘peroxide traffic
jam’ that could lead to the pro-oxidant effect of
Vitamin E.
Conformational analysis on vitamin E models with
both the fused ring and the side-chain tail undeter-
mined in the past by ab initio computations is now
investigated with the premise of further understanding
the role of vitamin E in eliminating ‘reactive oxygen
species’ ROS [5].
2. Methods
As a progression from previous studies where
concentration was placed on the fused ring systems,
the full model of the tocopherol family of compounds
is now studied. Outline of previous models studied is
shown in Fig. 1.
Since the previous calculations were modelled in a
modular, scalable and reusable manner, it is now
possible to add the side-chain tail to the fused ring.
Molecular computations were performed using the
Gaussian 98 [6] program package. Preliminary
conformers were constructed from initial model A
to the full tocopherol model. Energy is initially
minimized at the RHF/3-21G level of theory. These
minima are brought through to the RHF/6-31G(d) and
B3LYP/6-31G(d) levels of theory.
3. Results and discussions
The initial findings of the conformational study of
a-tocopherol are shown in Table 1. Considering the
nature of this publication, discussion will be kept to a
minimum and only focus on the side-chain tail
structure. A full analysis of both fused ring, and
side-chain will provided in future work.
The full a-tocopherol along with its congeners
have geometry optimized stable energy conformers
with all dihedrals of the side-chain in the anti position.
Fig. 2a shows the fully extended alpha-tocopherol
model optimized at the B3LYP/6-31g(d) level of
theory with all side-chain dihedrals in the anti
position. Fig. 2b shows geometry optimized energy
conformer of the hetero-atom substitution of selenium
computed at the RHF/6-31g(d) level of theory with all
side-chain dihedrals in the anti position.
A comparison is made of the sequence of stabiliz-
ation for various hetero-atoms. The geometrical
Fig. 1. Model map used for previous study of tocopherol families and selected congeners.
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Table 1
Optimized total energies and side-chain dihedral angles for stable conformers ðl ¼ 0Þ of a-tocopherol and its selected congeners
X Level
of theory
Dihedral
trend
Selected dihedral angles Total E (Har) Rel. E
(kcal
mol21)
DA(1) DB(1) DC(1) DD(1) DA(2) DB(2) DC(2) DD(2) DA(3) DB(3) DC(3) DD(3)
O RHF/3-
21G
a 173.35 187.27 183.68 170.94 189.24 175.99 183.97 170.47 189.34 175.92 183.52 171.57 21269.99688 –
O RHF/6-
31G(d)
a 178.35 187.92 186.73 172.06 189.07 174.86 185.25 171.06 188.77 174.60 184.55 172.26 21277.04046 –
O B3LYP/6-
31G(d)
a 176.52 185.55 184.65 171.76 189.31 175.40 184.25 170.88 188.58 175.11 183.21 171.70 21285.69823 –
S RHF/3-
21G
a 175.63 183.03 184.33 171.00 189.35 176.01 183.99 170.54 189.46 175.98 183.56 171.57 21591.10457 –
S RHF/6-
31G(d)
a 177.44 183.10 186.75 172.00 189.12 174.86 185.24 171.04 188.74 174.59 184.53 172.25 21599.68471 –
S B3LYP/6-
31G(d)
a 175.53 179.99 184.03 169.90 187.99 174.81 183.40 170.40 188.46 175.63 183.66 172.02 21608.66284
Se RHF/3-21G a 175.06 181.41 184.29 171.00 189.45 175.98 183.99 170.54 189.43 175.92 183.54 171.61 23584.04040 –
Se RHF/6-
31G(d)
a 176.59 183.86 186.47 171.95 189.09 174.90 185.27 171.09 188.78 174.60 184.55 172.26 23599.75844 –
Se B3LYP/6-
31G(d)
a Under computation
O RHF/3-21g a 173.35 187.27 183.68 170.94 189.24 175.99 183.97 170.47 189.34 175.92 183.52 171.57 21269.99688 0.000
O RHF/3-21g g þ 48.40 66.68 168.43 56.50 59.95 66.79 173.81 58.42 56.93 60.03 60.32 62.18 21269.99031 4.122
O RHF/3-21g g þ 41.71 65.21 101.24 62.52 56.07 61.30 172.01 57.64 57.32 58.56 58.65 61.42 21269.98435 3.741
O RHF/3-21g g 2 268.35 2104.44 268.97 260.51 245.90 269.95 257.45 256.49 263.48 2101.40 294.10 267.57 21269.97133 8.168
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parameters also show a non-monotonic change. The
R–C–Me bond angles at the ring stereo center varied
the following way: 112.28 (O), 111.68 (S), 112.28 (Se).
This is very similar to previous reported results of the
similar Et–C–Me bond angle for Model E which
were also non-monotonic 112.18 (O), 111.68 (S),
112.48 (Se). It is interesting to note that when
comparing the dihedral angles positioned further
away from the fused ring D[A,B,C,D](2) –
D[A,B,C,D](3), there is no significant difference
between the dihedrals of any of the congeners while
there is a monotonic change for the dihedral closest to
the fused ring.
Fig. 3 shows the selenium congener of the a-
tocopherol model optimized at B3LYP/6-31g(d) with
a g þ helices where the trend of the atoms in the
backbone of the a-tocopherol tail is to conform to the
g þ position.
The model of a-tocopherol with all side-chain tail
conformers in the anti position appears to have the
least energy of stabilization at this point. While the
model of a-tocopherol with all side-chain tail
conformers in the g 2 position appears to have the
largest energy of stabilization at this point
8.168 kcal mol21 from the lowest energy value
computer at the RHF/3-21g level of theory.
4. Conclusions
Taking into consideration the results shown is
only a partial set of a larger, comprehensive study,
further results are expected. The full study will
Fig. 2. (a) B3LYP/6-31G(d) optimized minimum energy structure for full extended tail structure of a-tocopherol and (b) B3LYP/6-31G(d)
optimized minimum energy of its selenium congener.
Fig. 3. B3LYP/6-31G(d) optimized minimum energy structure for
g þ trend of the side-chain tail for the selenium congener of a-
tocopherol.
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encompass all eight stereo isomers of all
homologues and possible congeners of the toco-
pherol model coupled with previously reported
results. This will allow a complete analysis of the
full conformational states of tocopherol.
A complete study of ring stability with respect
to gradual methylation as well as the trends of
biological activity should also be studied. It is
important to note that past studies have indicated
an inverse relationship between ring stability and
biological activity. A comprehensive structure
activity analysis of the full model will provide a
clearer answer.
With the full conformation space of the Vitamin E
models defined, the doors are open for modelling the
mechanisms of the antioxidant behaviour of toco-
pherol. Computations of the full structure of the
tocopherol family with respect to exothermic free
radical oxidative ring opening and endothermic ionic
ring closing can be examined. Computational model-
ling may also be able to shed light on Vitamin E’s role
as an oxidative protector of LDL [7] and its
relationships with enzymes such as gluthathione
peroxidase and catalase, and other bioactive mol-
ecules such as Vitamin C.
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